
<html lang="en"     class="pb-page"  data-request-id="b08b0d3a-22f3-4a38-aef3-fb9178c17b44"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.8b01869;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-9"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy" /></meta><meta name="dc.Creator" content="Jennifer R.  Riggs" /></meta><meta name="dc.Creator" content="Jan  Elsner" /></meta><meta name="dc.Creator" content="Dan  Cashion" /></meta><meta name="dc.Creator" content="Dale  Robinson" /></meta><meta name="dc.Creator" content="Lida  Tehrani" /></meta><meta name="dc.Creator" content="Mark  Nagy" /></meta><meta name="dc.Creator" content="Kimberly E.  Fultz" /></meta><meta name="dc.Creator" content="Rama  Krishna Narla" /></meta><meta name="dc.Creator" content="Xiaohui  Peng" /></meta><meta name="dc.Creator" content="Tam  Tran" /></meta><meta name="dc.Creator" content="Ashutosh  Kulkarni" /></meta><meta name="dc.Creator" content="Sogole  Bahmanyar" /></meta><meta name="dc.Creator" content="Kevin  Condroski" /></meta><meta name="dc.Creator" content="Barbra  Pagarigan" /></meta><meta name="dc.Creator" content="Gustavo  Fenalti" /></meta><meta name="dc.Creator" content="Laurie  LeBrun" /></meta><meta name="dc.Creator" content="Katerina  Leftheris" /></meta><meta name="dc.Creator" content="Dan  Zhu" /></meta><meta name="dc.Creator" content="John F.  Boylan" /></meta><meta name="dc.Description" content="Triple negative breast cancer (TNBC) is an aggressive disease with high relapse rates and few treatment options. Outlined in previous publications, we identified a series of potent, dual TTK/CLK2 i..." /></meta><meta name="Description" content="Triple negative breast cancer (TNBC) is an aggressive disease with high relapse rates and few treatment options. Outlined in previous publications, we identified a series of potent, dual TTK/CLK2 i..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 18, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01869" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01869" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01869" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01869" /></link>
        
    
    

<title>Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01869" /></meta><meta property="og:title" content="Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0016.jpeg" /></meta><meta property="og:description" content="Triple negative breast cancer (TNBC) is an aggressive disease with high relapse rates and few treatment options. Outlined in previous publications, we identified a series of potent, dual TTK/CLK2 inhibitors with strong efficacy in TNBC xenograft models. Pharmacokinetic properties and kinome selectivity were optimized, resulting in the identification of a new series of potent, selective, and orally bioavailable TTK inhibitors. We describe here the structure–activity relationship of the 2,4-disubstituted-7H-pyrrolo[2,3-d]pyrimidine series, leading to significant single agent efficacy in a TNBC xenograft model without body weight loss. The design effort evolving an iv-dosed TTK/CLK2 inhibitor to an orally bioavailable TTK inhibitor is described." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01869"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01869">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01869&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01869&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01869&amp;href=/doi/10.1021/acs.jmedchem.8b01869" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 4401-4410</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01821" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01923" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jennifer R. Riggs</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennifer R. Riggs</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#462c342f2121350625232a212328236825292b"><span class="__cf_email__" data-cfemail="b1dbc3d8d6d6c2f1d2d4ddd6d4dfd49fd2dedc">[email protected]</span></a>. Phone: 858-795-4854.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+R.++Riggs">Jennifer R. Riggs</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9012-1428" title="Orcid link">http://orcid.org/0000-0001-9012-1428</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jan Elsner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jan Elsner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Elsner">Jan Elsner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dan Cashion</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dan Cashion</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Cashion">Dan Cashion</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dale Robinson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dale Robinson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dale++Robinson">Dale Robinson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lida Tehrani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lida Tehrani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lida++Tehrani">Lida Tehrani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark Nagy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark Nagy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Nagy">Mark Nagy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kimberly E. Fultz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kimberly E. Fultz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly+E.++Fultz">Kimberly E. Fultz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rama Krishna Narla</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rama Krishna Narla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rama++Krishna+Narla">Rama Krishna Narla</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaohui Peng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaohui Peng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaohui++Peng">Xiaohui Peng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tam Tran</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tam Tran</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tam++Tran">Tam Tran</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ashutosh Kulkarni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ashutosh Kulkarni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ashutosh++Kulkarni">Ashutosh Kulkarni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sogole Bahmanyar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sogole Bahmanyar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sogole++Bahmanyar">Sogole Bahmanyar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin Condroski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin Condroski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Condroski">Kevin Condroski</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5801-9332" title="Orcid link">http://orcid.org/0000-0002-5801-9332</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barbra Pagarigan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barbra Pagarigan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barbra++Pagarigan">Barbra Pagarigan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gustavo Fenalti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gustavo Fenalti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gustavo++Fenalti">Gustavo Fenalti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laurie LeBrun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laurie LeBrun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laurie++LeBrun">Laurie LeBrun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katerina Leftheris</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katerina Leftheris</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katerina++Leftheris">Katerina Leftheris</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dan Zhu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dan Zhu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Zhu">Dan Zhu</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">John F. Boylan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John F. Boylan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+F.++Boylan">John F. Boylan</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01869&amp;href=/doi/10.1021%2Facs.jmedchem.8b01869" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 4401–4410</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 18, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 November 2018</li><li><span class="item_label"><b>Published</b> online</span>18 April 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01869" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01869</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4401%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJennifer%2BR.%2BRiggs%252C%2BJan%2BElsner%252C%2BDan%2BCashion%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D9%26contentID%3Dacs.jmedchem.8b01869%26title%3DDesign%2Band%2BOptimization%2BLeading%2Bto%2Ban%2BOrally%2BActive%2BTTK%2BProtein%2BKinase%2BInhibitor%2Bwith%2BRobust%2BSingle%2BAgent%2BEfficacy%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4410%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01869"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2012</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01869" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;R. Riggs&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Elsner&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Cashion&quot;},{&quot;first_name&quot;:&quot;Dale&quot;,&quot;last_name&quot;:&quot;Robinson&quot;},{&quot;first_name&quot;:&quot;Lida&quot;,&quot;last_name&quot;:&quot;Tehrani&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Nagy&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;E. Fultz&quot;},{&quot;first_name&quot;:&quot;Rama&quot;,&quot;last_name&quot;:&quot;Krishna Narla&quot;},{&quot;first_name&quot;:&quot;Xiaohui&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Tam&quot;,&quot;last_name&quot;:&quot;Tran&quot;},{&quot;first_name&quot;:&quot;Ashutosh&quot;,&quot;last_name&quot;:&quot;Kulkarni&quot;},{&quot;first_name&quot;:&quot;Sogole&quot;,&quot;last_name&quot;:&quot;Bahmanyar&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Condroski&quot;},{&quot;first_name&quot;:&quot;Barbra&quot;,&quot;last_name&quot;:&quot;Pagarigan&quot;},{&quot;first_name&quot;:&quot;Gustavo&quot;,&quot;last_name&quot;:&quot;Fenalti&quot;},{&quot;first_name&quot;:&quot;Laurie&quot;,&quot;last_name&quot;:&quot;LeBrun&quot;},{&quot;first_name&quot;:&quot;Katerina&quot;,&quot;last_name&quot;:&quot;Leftheris&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;F. Boylan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;4401-4410&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01869&quot;},&quot;abstract&quot;:&quot;Triple negative breast cancer (TNBC) is an aggressive disease with high relapse rates and few treatment options. Outlined in previous publications, we identified a series of potent, dual TTK/CLK2 inhibitors with strong efficacy in TNBC xenograft models. Pharmacokinetic properties and kinome selectivity were optimized, resulting in the identification of a new series of potent, selective, and orally bioavailable TTK inhibitors. We describe here the structure–activity relationship of the 2,4-disubstituted-7H-pyrrolo[2,3-d]pyrimidine series, leading to significant single agent efficacy in a TNBC xenograft model without body weight loss. The design effort evolving an iv-dosed TTK/CLK2 inhibitor to an orally bioavailable TTK inhibitor is described.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01869&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01869" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01869&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01869" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01869&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01869" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01869&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01869&amp;href=/doi/10.1021/acs.jmedchem.8b01869" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01869" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01869" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01869%26sid%3Dliteratum%253Aachs%26pmid%3D30998356%26genre%3Darticle%26aulast%3DRiggs%26date%3D2019%26atitle%3DDesign%2Band%2BOptimization%2BLeading%2Bto%2Ban%2BOrally%2BActive%2BTTK%2BProtein%2BKinase%2BInhibitor%2Bwith%2BRobust%2BSingle%2BAgent%2BEfficacy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D9%26spage%3D4401%26epage%3D4410%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/jmcmar.2019.62.issue-9/20190509/jmcmar.2019.62.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Triple negative breast cancer (TNBC) is an aggressive disease with high relapse rates and few treatment options. Outlined in previous publications, we identified a series of potent, dual TTK/CLK2 inhibitors with strong efficacy in TNBC xenograft models. Pharmacokinetic properties and kinome selectivity were optimized, resulting in the identification of a new series of potent, selective, and orally bioavailable TTK inhibitors. We describe here the structure–activity relationship of the 2,4-disubstituted-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine series, leading to significant single agent efficacy in a TNBC xenograft model without body weight loss. The design effort evolving an iv-dosed TTK/CLK2 inhibitor to an orally bioavailable TTK inhibitor is described.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73706" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73706" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In our previous work, we reported a dual inhibitor of TTK protein kinase (monopolar spindle 1, Mps1), and CDC2-like kinase (CLK2), identified from a triple negative breast cancer (TNBC) phenotypic screen.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> This series was optimized to provide an inhibitor with significant single agent efficacy upon once weekly iv dosing and ultimately lead to the nomination of CC-671 for IND-enabling studies. Although once weekly administration allows for an iv dosing paradigm, the flexibility of an oral dosing regimen is an important clinical consideration. As TNBC remains a high unmet medical need with few treatment options, we used CC-671 as a starting point to develop an oral, TTK-selective inhibitor.</div><div class="NLM_p">Cellular mechanism of action studies confirmed inhibition of both TTK and CLK2 by CC-671.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Significant single agent in vivo efficacy of this compound was attributed to increased apoptosis from accelerated mitotic exit, mechanistically linked to TTK inhibition. TTK is a dual serine/threonine kinase that controls the progression of cells through mitosis by regulating the spindle assembly checkpoint.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> TTK has been shown to be a promising target for TNBC. TTK knockout by siRNA induced apoptosis in TNBC cell lines by accelerating mitotic progression.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Elevated TTK expression in TNBC tumors is correlated with a poor patient prognosis.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Because of the high interest in the target, a number of potent TTK inhibitors have been described with five reportedly entering phase I clinical trials.<a onclick="showRef(event, 'ref5 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref5 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18">(5,7−18)</a></div><div class="NLM_p">Here, we describe the identification of orally efficacious TTK inhibitors derived from CC-671 (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and the structure–activity relationship (SAR) optimization leading to good oral bioavailability. Upon oral administration, lead compounds were well-tolerated and produced significant single agent efficacy in a TNBC xenograft study with good pharmacokinetic (PK)/pharmacodynamic (PD) correlation. This efficacy and tolerability profile was superior to the standard of care in TNBC, Docetaxel.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of iv starting point CC-671.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37154" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37154" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> details the synthesis of 2,4-disubstituted-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines. SEM-protection of 2,4-dichloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine provided intermediate <b>2</b>. Alcohol displacement of the C-4 chloride afforded intermediates <b>3a–h</b>. Pd-catalyzed C–N cross-coupling was utilized to install the C-2 substituent. Final analogues (<b>4–20</b>) were obtained after facile deprotection using either tetra-<i>n</i>-butylammonium fluoride (TBAF) or trifluoroacetic acid (TFA) followed by ammonium hydroxide-assisted cleavage of the hemiaminal intermediate in 2 steps.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>4–20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SEM-Cl, NaH, DMF, 0–22 °C; (b) R<sub>1</sub>-alcohol, 1,4-dioxane, NaO<i>t</i>Bu, 70–90 °C; (c) R<sub>2</sub>-amine, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C; (d) TFA, DCM; (e) NH<sub>4</sub>OH, MeOH; and (f) TBAF, THF, 50 °C.</p></p></figure><div class="NLM_p">To identify orally bioavailable TTK inhibitors, our strategy was to retain TTK inhibitory activity and TNBC sensitivity of CC-671 (<b>1</b>) while focusing on improving the physicochemical properties of analogues in an effort to obtain good oral exposure. The antiproliferative potency in CAL-51, a TNBC cell line, was utilized to evaluate analogues and drive the SAR. Compound <b>1</b> has poor oral exposure (0.9% F, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Table 1), which could be attributed in part to the high molecular weight, polar surface area, and cLog <i>P</i> of <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Utilizing <b>1</b> as a starting point, the C-5 substituent was truncated, removing the acid-labile benzoxazole group. In addition, the amide NH at C-2 was methylated, removing one H-bond donor, providing <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Although the potency of <b>4</b> is reduced by 10-fold in the TNBC cell assay, the improved physicochemical properties of <b>4</b> provide a more efficient starting point for optimization of potency and oral exposure.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Modification of <b>1</b> Leads To Improved Physicochemical Properties</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0009.gif" alt="" id="GRAPHIC-d7e450-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">analog</th><th class="colsep0 rowsep0" align="center" char=".">CAL-51 potency IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">mol wt</th><th class="colsep0 rowsep0" align="center">PSA<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">cLog <i>P</i><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.028</td><td class="colsep0 rowsep0" align="left">513</td><td class="colsep0 rowsep0" align="left">127</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">0.497</td><td class="colsep0 rowsep0" align="left">395</td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Mean reported, SEM available in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Table 2.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Pipeline pilot calculation.</p></div></div></div><div class="NLM_p">The SAR at the C-4 position was explored with the goal of improving potency and kinase selectivity while maintaining drug-like properties (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). A subset of kinases was used as a representation of overall selectivity against a larger kinase panel (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Table 3). Replacement of the cyclopentyl as in oxetane <b>5</b> or isopropyl <b>6</b> resulted in a loss of CAL-51 potency. Cyclohexyl <b>7</b> and tetrahydropyran (THP) <b>8</b> improved cellular potency as compared to the cyclopentyl <b>4</b>, despite equivalent TTK enzyme potency. Considerable potency gains were obtained with cyclohexanols <b>9</b> and <b>10</b>, but at the expense of kinase selectivity, which could be contributing to the observed cellular efficacy. Notably, <i>gem</i>-dimethyl-substituted THP <b>11</b> affords considerable kinase selectivity compared to cyclohexanols <b>9</b> and <b>10</b> and favorable potency. The <i>gem</i>-dimethyl-substituted THP at C-4 was held constant to explore the C-6 para-position SAR with the goal of optimizing potency (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In parallel, we held the C-4 methyl cyclohexanol constant to explore the C-6 ortho-position SAR to optimize selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Overall, the TTK enzyme potency correlated with the CAL-51 proliferation assay, although the dynamic range of the enzyme assay for these compounds was far narrower. For this reason, antiproliferative activity in CAL-51 was used as the primary potency measure to drive the SAR, together with overall kinase selectivity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. C-4 Position SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0010.gif" alt="" id="GRAPHIC-d7e596-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0011.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Mean reported, SEM available in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Table 2.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Pipeline pilot calculation.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Single point assessment at 3 μM.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last"><i>n</i> = 1.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. C-2 Position SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0012.gif" alt="" id="GRAPHIC-d7e630-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0013.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Mean reported, SEM available in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Table 2.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Pipeline pilot calculation.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Dose 10 mg/kg.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Single point assessment at 3 μM.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Formulated in CMCT (0.5% CMC/0.25% Tween-80).</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">Formulated in 5% TPGS (<span class="smallcaps smallerCapital">d</span>-α-tocopheryl polyethylene glycol 1000 succinate), 10% captisol, 50 mM citrate buffer.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. C-2 and C-5 Position SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0014.gif" alt="" id="GRAPHIC-d7e675-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0015.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Mean reported, SEM available in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Table 2.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Pipeline pilot calculation.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Dose 10 mg/kg.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Single point assessment at 3 μM.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Formulated in CMCT (0.5% CMC/0.25% Tween-80).</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Formulated in 5% TPGS (<span class="smallcaps smallerCapital">d</span>-α-tocopheryl polyethylene glycol 1000 succinate), 10% captisol, 50 mM citrate buffer.</p></div></div><div></div></div><div class="NLM_p">We then explored para-substitution (R3) on the C-2 aryl group (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Based on structural data previously reported, many substituents should be well tolerated in this solvent-exposed region.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The oral exposure and selectivity of <b>11</b> were high, serving as a starting point for further SAR with the goal of improving potency and properties. Morpholine amide <b>12</b> resulted in a potency loss. Deletion of the amide carbonyl providing direct-linked morpholine (<b>13</b>) resulted in a potency gain as compared to both <b>11</b> and <b>12</b>. Both hydrogen bond donors and acceptors were tolerated at this position (<b>13</b> and <b>14</b>) and resulted in a modest potency increase as compared to amide <b>11</b>. The additional hydrogen bond donors/acceptors and increased molecular weight of <b>14</b> and <b>15</b> lead to a decrease in oral exposure as compared to <b>11</b>. Oxetane <b>16</b> had increased oral exposure as compared to <b>14</b> and <b>15</b> and a small increase in potency compared to <b>11</b>. All analogues made in this C-2 exploration maintained reasonable kinase selectivity similar to <b>11</b>, likely due to the C-4 <i>gem</i>-dimethyl THP.</div><div class="NLM_p">While the <i>gem</i>-dimethyl THP at C-4 afforded improved kinase selectivity, this was often at the expense of potency (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <b>11</b> compared to <b>10</b>). Compound <b>10</b> had attractive potency but poor selectivity. Using available structural information, we knew that TTK would tolerate larger substituents at the ortho-position of C-2, and this was a potential selectivity handle.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> To optimize for selectivity, we kept the methyl cyclohexanol constant and explored a variety of ortho-substituents on C-2 (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Replacing the methoxy (<b>10</b>) with ethoxy (<b>17</b>) resulted in an improvement in potency and kinase selectivity. The trifluoroethyl <b>18</b> further improved potency and enhanced kinase selectivity. Stereoselective addition of a methyl substituent to <b>18</b> resulted in a highly selective and potent analog <b>19</b>. Additional potency was gained by substituting C-5 of <b>19</b> with a Cl (<b>20</b>). These changes had a relatively minor effect on oral exposure despite increased molecular weight.</div><div class="NLM_p">Compounds <b>15</b>, <b>16</b>, and <b>20</b> showed nanomolar potency against the TTK enzyme, reduction of the cellular substrate (<i>p</i>-TTK), and strong antiproliferative activity (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Compound <b>20</b> exhibited the most potent activity across multiple assays. The correlation of the cellular biomarker <i>p</i>-TTK and proliferation in the CAL-51 cell line was good for the series (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CAL-51 proliferation compared to CAL-51 <i>p</i>-TTK.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. TTK Enzyme, CAL-51 <i>p</i>-TTK, and Proliferation Data for <b>15</b>, <b>16</b>, and <b>20</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">analog</th><th class="colsep0 rowsep0" align="center" char=".">TTK enzyme IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">CAL-51 <i>p</i>-TTK IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">CAL-51 potency IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"># kinases >80% inh<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0013</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">0.037</td><td class="colsep0 rowsep0" align="left">10/46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0025</td><td class="colsep0 rowsep0" align="char" char=".">0.044</td><td class="colsep0 rowsep0" align="char" char=".">0.084</td><td class="colsep0 rowsep0" align="left">7/46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0007</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="left">10/46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">10/258</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Mean reported, SEM available in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Table 2.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Single point assessment at 3 μM.</p></div></div></div><div class="NLM_p">To further characterize the compound effect on the TTK pathway in cells, inhibition of phosphorylation of KNL1, a direct TTK substrate, in addition to TTK autophosphorylation, was measured as a cellular PD marker. Western blot analysis was conducted using CAL-51 cells treated with increasing concentrations of compound <b>20</b> for 1 h (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Compound <b>20</b> potently inhibits phosphorylation of both TTK substrates with a <i>p</i>-TTK IC<sub>50</sub> of 11 nM (approximately 5-fold more potent than our starting point <b>1</b>, IC<sub>50</sub> = 57 nM) and <i>p</i>-KNL1 IC<sub>50</sub> of 30 nM.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. TTK substrate phosphorylation inhibition post treatment with compound <b>20</b> as measured by western blot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A co-crystal structure of <b>20</b> with TTK was obtained at 2.4 Å resolution (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The crystal structure reveals a ligand-dependent, induced-fit conformation of the TTK catalytic kinase domain (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Figure 1).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The pyrrolopyrimidine core interacts with the ATP binding pocket and forms three hydrogen bonds to the hinge region. The pyrrole NH (N-7) hydrogen bonds to the backbone carbonyl of Glu603, and the aminopyrimidine forms two hydrogen bond interactions with Gly605. The methyl cyclohexanol at C-4 binds in the ribose pocket, and the chlorine at C-5 binds deeper in the pocket in proximity of catalytic Lys553 and gate-keeper residue Met602. Both substituents at C-4 and C-5 are stabilized by extensive hydrophobic and van der Waals interactions in the TTK binding site (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Figure 1).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The C-2 aniline substituent binds in the solvent pocket, and the <i>ortho</i>-(<i>R</i>)-(1,1,1-trifluoropropan-2-yl)oxy substituent forms stabilizing polar and hydrophobic interactions in a pocket formed by G-loop residues Glu541, Lys529, and Ile531, along with hinge residue Cys604.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This unique arrangement of residues allows for this bulky substituent to be tolerated in the hinge region of TTK and contribute to broad kinome selectivity.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Co-crystal structure of <b>20</b> bound in the ATP pocket of TTK. Residues within 4.0 Å of the ligand are shown (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N6O">6N6O</a>). The activation loop (residues 670–684) is disordered and not resolved in the crystal structure (some residues eliminated for clarity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Selectivity of compound <b>20</b> was further assessed against 258 kinases. Only 9 kinases other than TTK were strongly inhibited (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Table 4).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Four kinases had IC<sub>50</sub> values within 100-fold of TTK; LRRK2 G2019S, LRRK2, JNK1 and 2 (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. 10/259 Kinases Inhibited >80% after 3 μM Treatment with Compound <b>20</b> [IC<sub>50</sub> (μM)]</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">TTK</th><th class="colsep0 rowsep0" align="center">LRRK2 G2019S</th><th class="colsep0 rowsep0" align="center">LRRK2</th><th class="colsep0 rowsep0" align="center">JNK1</th><th class="colsep0 rowsep0" align="center">JNK2</th><th class="colsep0 rowsep0" align="center">DYRK3</th><th class="colsep0 rowsep0" align="center">JNK3</th><th class="colsep0 rowsep0" align="center">TSSK1</th><th class="colsep0 rowsep0" align="center">CLK2</th><th class="colsep0 rowsep0" align="center">Ltk</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>0.0007</b></td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">0.032</td><td class="colsep0 rowsep0" align="left">0.059</td><td class="colsep0 rowsep0" align="left">0.104</td><td class="colsep0 rowsep0" align="left">0.107</td><td class="colsep0 rowsep0" align="left">0.217</td><td class="colsep0 rowsep0" align="left">0.261</td><td class="colsep0 rowsep0" align="left">0.567</td></tr></tbody></table></div></div><div class="NLM_p">Our SAR optimization resulted in the identification of multiple analogues with good potency, selectivity, and oral exposure in rat. Mouse PK studies were used to select the top candidates for in vivo xenograft studies. Three representative compounds are detailed in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> along with their oral PK in rat and mouse. Compounds <b>15</b>, <b>16</b>, and <b>20</b> afforded good oral exposure in mouse with <i>C</i><sub>max</sub> values between 5 and 10 μM and AUC values from 17 to 35 μM·h when dosed at 30 mg/kg. Compound <b>20</b> had an oral bioavailability of 60% in mouse (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Table 5).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. PK Properties of Selected Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">rat PO PK<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t7fn3" aria-label="c">c</a><sup>,</sup><a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">mouse PO PK<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t7fn3" aria-label="c">c</a><sup>,</sup><a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">analog</th><th class="colsep0 rowsep0" align="center">human S9 met. stability<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center">AUC (μM·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (μM·h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="char" char=".">2.53</td><td class="colsep0 rowsep0" align="left">9.52</td><td class="colsep0 rowsep0" align="char" char=".">9.86</td><td class="colsep0 rowsep0" align="char" char=".">17.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="char" char=".">4.43<a class="ref internalNav" href="#t7fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">24<a class="ref internalNav" href="#t7fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">11.8</td><td class="colsep0 rowsep0" align="char" char=".">35.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="char" char=".">4.35</td><td class="colsep0 rowsep0" align="left">26.3</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">22.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">% remaining at 60 min.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Mean reported, SEM available in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Table 2.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">Formulated as a solution in CMCT (0.5% CMC/0.25% Tween-80).</p></div><div class="footnote" id="t7fn4"><sup><sup>d</sup></sup><p class="last">Dose 10 mg/kg.</p></div><div class="footnote" id="t7fn5"><sup><sup>e</sup></sup><p class="last">Dose 30 mg/kg in SCID mice.</p></div><div class="footnote" id="t7fn6"><sup><sup>f</sup></sup><p class="last">Formulated in 5% TPGS (<span class="smallcaps smallerCapital">d</span>-α-tocopheryl polyethylene glycol 1000 succinate), 10% captisol, 50 mM citrate buffer.</p></div></div></div><div class="NLM_p">Compound <b>20</b> exhibited promising cellular potency, selectivity, and acceptable oral rat and mouse PK. In vivo efficacy assessment was performed using a CAL-51 mouse xenograft model. The compound was administered every seven days (QW) for 16 days measuring tumor growth compared to vehicle control and body weight loss (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Compound <b>20</b> demonstrated a dose-dependent increase in efficacy from 30 to 120 mg/kg QD QW. With a tumor growth inhibition (TGI) of 59%, only the 30 mg/kg QW dose failed to produce significant TGI as defined by [(vehicle – treated/vehicle) × 100%] of >60% (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). <i>C</i><sub>max</sub> and AUC values were dose proportional through 90 mg/kg. We sought to explore whether efficacy was predominantly <i>C</i><sub>max</sub> or AUC-driven. One dose group of BID QW was added to assess the effect of sustained AUC over the IC<sub>50</sub>. Interestingly, the 30 mg/kg BID QW dose group produced 84% TGI, while the equivalent overall dose, 60 mg/kg QD QW, produced a lower 65% TGI. These data suggest that the efficacy is predominantly AUC-driven. All dosing groups were well-tolerated without appreciable BWL. Although LRRK is also likely inhibited at these doses, LRRK is not expressed in this cell line and therefore does not contribute to efficacy. The potential pulmonary toxicity highlighted in the literature from LRRK inhibition requires additional in vivo assessment.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> BID and QD QW oral dosing of compound <b>20</b> were generally more efficacious and better tolerated than Docetaxel (BWL in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>, Figure 2). Docetaxel was administered at 5 mg/kg, Q4D, the maximum tolerated dose leading to 20% BWL. Suspended dosing of Docetaxel was necessary to allow for recovery and provided a modest TGI of 61%. In the CAL-51 xenograft model, compound <b>20</b> has a superior efficacy and tolerability profile compared to Docetaxel, the current standard of care for TNBC.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. CAL-51 tumor xenograft studies with BID and QD once weekly dosing of compound <b>20</b>. On day 31, all treatment groups were significantly (*<i>p</i> < 0.001, one way ANOVA) different compared to the vehicle-treated group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>20</b> was also assessed in a single dose biomarker study measuring the mitotic cell cycle marker, phosphohistone H3 (pHH3), and tumor cell apoptosis marker, cleaved caspase-3 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). A single dose of 10 or 30 mg/kg in mice caused considerable reduction in pHH3 after 1 h, maintained through 48 h, for the 30 mg/kg dose. Significant cleaved caspase-3 induction occurred at both 10 and 30 mg/kg as compared to vehicle (159 and 250%, respectively). The maximal amount of caspase-3 induction was achieved at 48 h post dose. These data confirm proximal on-target biomarker reduction (pHH3) and apoptosis.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Single dose study with compound <b>20</b> measuring PK, pHH3, and cleaved caspase in CAL-51 tumors (*<i>p</i> < 0.05, ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001 one way ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20378" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20378" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have detailed the optimization and SAR of the 2,4-disubstituted-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine series of oral TTK inhibitors. Starting from our lead iv preclinical candidate, we successfully identified potent, selective, and orally bioavailable TTK inhibitors. Truncation of the iv lead <b>1</b> provided starting points with improved physicochemical properties. SAR optimization, starting from compound <b>4</b>, lead to improved selectivity and potency with good oral exposure in the series. Interestingly, the overall physiochemical property space occupied by compound <b>20</b> is not significantly different from compound <b>1</b>, but the oral exposure of compound <b>20</b> and similar analogues is far superior. These compounds occupying “unideal property space” while maintaining good oral exposure support the notion that strict adherence to the rule of five (Ro5) is not always necessary.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Compound <b>20</b> showed significant reduction in pHH3 and induction of cleaved caspase-3 in an in vivo tumor biomarker study. Apoptotic induction produced significant efficacy in CAL-51 cell lines in vitro and in vivo in the xenograft model. Compound <b>20</b> represents a highly competitive, oral TTK inhibitor with strong single agent efficacy in a TNBC xenograft model.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03343" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03343" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3><div class="NLM_p">Compounds were named using ChemDraw Ultra. All materials were obtained from commercial sources unless otherwise noted and used without further purification. Chromatography solvents were high-performance liquid chromatography (HPLC) grade. Air-sensitive reactions were performed under a positive pressure of an inert nitrogen atmosphere. <sup>1</sup>H NMR spectra were obtained on 300, 400, or 500 MHz spectrometers. Chemical shifts are relative to tetramethylsilane as the internal standard or relative to a residual solvent peak. Chemical shifts (δ) are reported in ppm, and coupling constants (<i>J</i>) are given in Hz. Liquid chromatography–mass spectrometry (LCMS) analysis was performed on a PE SCIEX ESI MS or Agilent 1100 MS. Semi-preparative reverse phase HPLC was performed on a Shimadzu system utilizing a Phenomenex 15 micron C18 column (250 × 10 mm). Preparative reverse phase HPLC was performed on a Shimadzu system equipped with a Phenomenex 15 micron C18 column (250 × 50 mm). Thin layer chromatography analysis was performed on Whatman thin layer plates. Compounds were analyzed for purity by either: (A) gradient (0–75% acetonitrile + 0.1% formic acid in water + 0.1% formic, over 7 min, followed by 75% acetonitrile + 0.1% formic acid for 2 min); flow rate 1 mL/min, Column Phenomenex Gemini-NX 5u C18 110A (50 × 4.60 mm); (B) gradient (0–75% acetonitrile + 0.1% formic acid in water + 0.1% formic, over 20 min, followed by 75% acetonitrile + 0.1% formic acid for 5 min); flow rate 1 mL/min, Column Phenomenex Gemini-NX 5u C18 110A (250 × 4.60 mm). The purity of all final tested compounds was determined to be ≥95% by HPLC using an Agilent 1100 system with a reverse phase C18 column and diode array detector. Reported yields are unoptimized. Elemental analysis was performed at Robertson Microlit Laboratories, Ledgewood, New Jersey.</div><div class="NLM_p last">Synthetic procedures for all intermediates <b>2</b>, <b>3a–3h</b>, and <b>4–20 SEM</b> are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Procedure for the Synthesis of Compounds <b>4–20</b></h3><div class="NLM_p">The SEM protected pyrrolo[2,3-<i>d</i>]pyrimidine intermediate was treated with TFA (5–500 equiv) in dichloromethane (DCM) (1–5 times the volume of TFA). The mixture was stirred at room temperature for 1–24 h. The solvent was removed and the residue was stirred with aqueous ammonium hydroxide (10–30% solution, 2–100 equiv) in methanol or 1,4-dioxane (1–5 times the volume of ammonium hydroxide solution) with or without DCM (0.5–2.5 times the volume of methanol) at room temperature to 60 °C for 1–24 h. In cases where the compound contained aqueous acid-sensitive functionalities, the residue was treated with an excess of methanolic ammonia (2–7 N) prior to addition of the aqueous ammonium hydroxide. The final product was either collected by filtration or purified using standard techniques.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 4-((4-(Cyclopentyloxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-3-methoxy-<i>N</i>,<i>N</i>-dimethylbenzamide (<b>4</b>)</h4><div class="NLM_p last">Yield 0.109 g, 0.28 mmol, 69%, HPLC purity >95%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.50–11.59 (m, 1H), 8.59 (d, <i>J</i> = 8.31 Hz, 1H), 7.60 (s, 1H), 7.04 (br d, <i>J</i> = 13.94 Hz, 3H), 6.26–6.32 (m, 1H), 5.55–5.63 (m, 1H), 3.93 (s, 3H), 2.99 (s, 6H), 1.97–2.10 (m, 2H), 1.70–1.86 (m, 4H), 1.54–1.69 (m, 2H). MS (ESI) <i>m</i>/<i>z</i>: 396.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 3-Methoxy-<i>N</i>,<i>N</i>-dimethyl-4-((4-(oxetan-3-yloxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)benzamide (<b>5</b>)</h4><div class="NLM_p last">To a solution of 3-methoxy-<i>N</i>,<i>N</i>-dimethyl-4-((4-(oxetan-3-yloxy)-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)benzamide (<b>5 SEM</b>) (0.240 g, 0.467 mmol) in THF (2.3 mL) was added TBAF (2.3 mL, 2.3 mmol). The mixture was placed under nitrogen and heated to 50 °C for 18 h. The volatiles were removed by rotary evaporation. The residue was purified by semi-preparative HPLC to obtain the title compound (0.027 g, 0.068 mmol, 15% yield, HPLC purity >96%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.87–0.99 (m, 2H), 1.22–1.38 (m, 1H), 1.47–1.63 (m, 1H), 2.90–3.06 (m, 4H), 3.10–3.22 (m, 1H), 3.24–3.45 (m, 2H), 3.91 (s, 2H), 4.65 (dd, <i>J</i> = 7.81, 5.08 Hz, 1H), 4.95 (t, <i>J</i> = 7.23 Hz, 1H), 5.69–5.81 (m, 1H), 6.36 (d, <i>J</i> = 3.12 Hz, 1H), 7.01–7.12 (m, 2H), 7.62 (s, 1H), 8.46 (d, <i>J</i> = 8.59 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i>: 384.1 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 4-((4-Isopropoxy-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-3-methoxy-<i>N</i>,<i>N</i>-dimethylbenzamide (<b>6</b>)</h4><div class="NLM_p last">Yield 0.11 g, 0.288 mmol, 62%, HPLC purity >95%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.46–11.62 (m, 1H), 8.58 (d, <i>J</i> = 8.31 Hz, 1H), 7.52–7.64 (m, 1H), 6.96–7.12 (m, 3H), 6.30 (dd, <i>J</i> = 3.42, 1.96 Hz, 1H), 5.42–5.55 (m, 1H), 3.93 (s, 3H), 2.99 (s, 5H), 2.94 (s, 1H), 1.38 (d, <i>J</i> = 6.11 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i>: 370.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 4-((4-(Cyclohexyloxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-3-methoxy-<i>N</i>,<i>N</i>-dimethylbenzamide (<b>7</b>)</h4><div class="NLM_p last">Yield 0.054 g, 0.13 mmol, 23% over two steps, HPLC purity >97%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.48–11.55 (m, 1H), 8.52–8.57 (m, 1H), 7.58–7.63 (m, 1H), 7.05–7.08 (m, 1H), 6.99–7.05 (m, 2H), 6.28–6.33 (m, 1H), 5.18–5.29 (m, 1H), 3.92 (s, 3H), 2.99 (s, 6H), 2.00–2.11 (m, 2H), 1.73–1.83 (m, 2H), 1.28–1.63 (m, 6H). MS (ESI) <i>m</i>/<i>z</i>: 410.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 3-Methoxy-<i>N</i>,<i>N</i>-dimethyl-4-((4-((tetrahydro-2<i>H</i>-pyran-4-yl)oxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)benzamide (<b>8</b>)</h4><div class="NLM_p last">Yield 0.092 g, 0.225 mmol, 35%, HPLC purity >98%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.58 (s, 1H), 8.55–8.53 (d, <i>J</i> = 8.4 Hz, 1H), 7.66 (s, 1H), 7.07–7.03 (m, 3H), 6.34–6.33 (d, <i>J</i> = 2 Hz, 1H), 5.43–5.41 (m, 1H), 3.92–3.90 (d, <i>J</i> = 9.6 Hz, 5H), 3.58–3.53 (m, 2H), 2.99 (s, 6H), 2.11–2.08 (m, 2H), 1.75–1.70 (m, 2H). MS (ESI) <i>m</i>/<i>z</i>: 412.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 4-((4-(((1r,4r)-4-Hydroxy-4-methylcyclohexyl)oxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-3-methoxy-<i>N</i>,<i>N</i>-dimethylbenzamide (<b>9</b>)</h4><div class="NLM_p last">Yield 0.046 g, 0.105 mmol, 22% over 2 steps, HPLC purity >99%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.52 (s, 1H), 8.55 (d, <i>J</i> = 8.31 Hz, 1H), 7.61 (s, 1H), 6.99–7.09 (m, 3H), 6.31 (dd, <i>J</i> = 1.96, 3.42 Hz, 1H), 5.30–5.37 (m, 1H), 4.24 (s, 1H), 3.92 (s, 3H), 2.99 (s, 6H), 1.95–2.06 (m, 2H), 1.61–1.76 (m, 4H), 1.44–1.55 (m, 2H), 1.18 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 440.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 4-((4-(((1s,4s)-4-Hydroxy-4-methylcyclohexyl)oxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-3-methoxy-<i>N</i>,<i>N</i>-dimethylbenzamide (<b>10</b>)</h4><div class="NLM_p last">Yield 0.171 g, 0.39 mmol, 59%, HPLC purity >98%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.53 (s, 1H), 8.55 (d, <i>J</i> = 8.4 Hz, 1H), 7.60 (s, 1H), 7.06–7.01 (m, 3H), 6.31–6.30 (m, 1H), 5.19–5.15 (m, 1H), 4.21 (s, 1H), 3.92 (s, 3H), 2.99 (s, 6H), 1.89–1.84 (m, 4H), 1.67–1.64 (m, 2H), 1.52–1.45 (m, 2H), 1.16 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 440.3 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>S</i>)-4-(4-(2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yloxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-ylamino)-3-methoxy-<i>N</i>,<i>N</i>-dimethylbenzamide (<b>11</b>)</h4><div class="NLM_p last">Yield after chiral separation 0.82 g, 0.187 mmol, 20%, HPLC purity >99%, ee > 95%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.65 (d, <i>J</i> = 8.4 Hz, 1H), 7.08 (d, <i>J</i> = 2.0 Hz, 1H), 7.04 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 6.94 (d, <i>J</i> = 3.6 Hz, 1H), 6.35 (d, <i>J</i> = 3.6 Hz, 1H), 5.70–5.63 (m, 1H), 3.98 (s, 3H), 3.94–3.82 (m, 2H), 3.10 (s, 6H), 2.17–2.12 (m, 2H), 1.81–1.74 (m, 1H), 1.70–1.64 (m, 1H), 1.36 (s, 3H), 1.31 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 440.2 [M + 1]<sup>+</sup>. Anal. Calcd for (%) C<sub>23</sub>H<sub>29</sub>N<sub>5</sub>O<sub>4</sub>·0.4H<sub>2</sub>O: C, 61.84; H, 6.72; N, 15.68. Found: C, 61.81; H, 6.84; N, 15.62.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>S</i>)-(4-((4-((2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)oxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-3-methoxyphenyl)(morpholino)methanone (<b>12</b>)</h4><div class="NLM_p last">To a vial was added (<i>S</i>)-4-((4-((2,2-dimethyltetrahydro-2H-pyran-4-yl)oxy)-7H-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-3-methoxybenzoic acid (0.100 g, 0.242 mmol), morpholine (0.027 mL, 0.315 mmol), HATU (0.111 g, 0.291 mmol), dimethylformamide (DMF) (1.5 mL), and DIEA (0.169 mL, 0.970 mmol). The mixture was stirred at room temperature for 2 h. The mixture was diluted with DMSO (1 mL) and purified by semi-preparative HPLC to obtain the title compound (0.073 g, 0.152 mmol, 63% yield, HPLC purity >99%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.50–11.58 (m, 1H), 8.53 (d, <i>J</i> = 8.20 Hz, 1H), 7.67 (s, 1H), 7.07 (dd, <i>J</i> = 2.68, 14.97 Hz, 2H), 7.01 (dd, <i>J</i> = 1.58, 8.20 Hz, 1H), 6.32 (d, <i>J</i> = 3.47 Hz, 1H), 5.54–5.63 (m, 1H), 3.94 (s, 3H), 3.78–3.86 (m, 1H), 3.69–3.76 (m, 1H), 3.62 (br s, 4H), 3.54 (br s, 3H), 2.03–2.12 (m, 2H), 1.58–1.69 (m, 1H), 1.50–1.56 (m, 1H), 1.28 (s, 3H), 1.24 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 482.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i>)-4-((2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)oxy)-<i>N</i>-(2-methoxy-4-morpholinophenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>13</b>)</h4><div class="NLM_p last">Yield 0.058 g, 0.127 mmol, 79%, HPLC purity >99%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.32 (s, 1H), 8.01 (d, <i>J</i> = 8.83 Hz, 1 H), 7.37 (s, 1H), 6.94 (dd, <i>J</i> = 3.47, 2.21 Hz, 1H), 6.66 (d, <i>J</i> = 2.52 Hz, 1H), 6.48 (dd, <i>J</i> = 8.83, 2.84 Hz, 1H), 6.24 (dd, <i>J</i> = 3.47, 1.89 Hz, 1H), 5.42–5.55 (m, 1H), 3.85 (s, 2H), 3.74–3.78 (m, 3H), 3.65–3.81 (m, 5H), 3.05–3.12 (m, 3H), 2.03 (dd, <i>J</i> = 12.30, 4.41 Hz, 1H), 1.55–1.63 (m, 1H), 1.50 (dd, <i>J</i> = 12.61, 10.40 Hz, 1H), 1.23 (d, <i>J</i> = 4.73 Hz, 4 H). MS (ESI) <i>m</i>/<i>z</i>: 454.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i>)-1-(4-((4-((2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)oxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-3-methoxyphenyl)-4-methylpiperidin-4-ol (<b>14</b>)</h4><div class="NLM_p last">Yield 0.075 g, 0.16 mmol, 43% over two steps, HPLC purity >95%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.30 (br s, 1H), 7.93 (d, <i>J</i> = 8.80 Hz, 1H), 7.34 (s, 1H), 6.89–6.94 (m, 1H), 6.62 (d, <i>J</i> = 2.20 Hz, 1H), 6.47 (dd, <i>J</i> = 2.08, 8.68 Hz, 1H), 6.22 (dd, <i>J</i> = 1.90, 3.36 Hz, 1H), 5.44–5.52 (m, 1H), 4.25 (s, 1H), 3.75–3.85 (m, 4H), 3.61–3.75 (m, 1H), 3.17–3.27 (m, 2H), 3.02–3.17 (m, 2H), 2.02 (br dd, <i>J</i> = 3.55, 11.98 Hz, 2H), 1.45–1.64 (m, 6H), 1.21 (d, <i>J</i> = 3.79 Hz, 6H), 1.13–1.18 (m, 3H). MS (ESI) <i>m</i>/<i>z</i>: 481.9 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>S</i>)-1-(4-(4-((4-((2,2-Dimethyltetrahydro-2<i>H</i>-pyran-4-yl)oxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-3-methoxyphenyl)piperazin-1-yl)-2-hydroxyethanone (<b>15</b>)</h4><div class="NLM_p last">To a solution of 2-hydroxyacetic acid (0.672 g, 8.84 mmol) in DMF (20 mL) was added HATU (3.7 g, 9.72 mmol), DIEA (4.63 mL, 26.5 mmol), and (<i>S</i>)-4-((2,2-dimethyltetrahydro-2<i>H</i>-pyran-4-yl)oxy)-<i>N</i>-(2-methoxy-4-(piperazin-1-yl)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (4 g, 8.84 mmol) sequentially. The mixture was stirred at room temperature 4 h. After the reaction was complete, as monitored by LCMS, the mixture was diluted with ethyl acetate, washed with saturated aqueous sodium chloride, and dried over anhydrous sodium sulfate. Concentrated and purified by semi-preparative HPLC to give the title compound (1.3 g, 2.55 mmol, 29% yield, HPLC purity >99%). <sup>1</sup>H NMR (400 MHz DMSO-<i>d</i><sub>6</sub>): δ 11.3–11.4 (m, 1H), 7.9–8.1 (m, 1H), 7.3–7.4 (m, 1H), 6.9–7.0 (m, 1H), 6.6–6.7 (m, 1H), 6.5–6.6 (m, 1H), 6.2–6.3 (m, 1H), 5.4–5.6 (m, 1H), 4.6–4.7 (m, 1H), 4.1–4.2 (m, 2H), 3.8–3.9 (m, 3H), 3.7–3.8 (m, 1H), 3.6–3.7 (m, 3H), 3.5–3.6 (m, 2H), 3.09 (br d, 4H, <i>J</i> = 3.2 Hz), 2.0–2.1 (m, 2H), 1.4–1.7 (m, 2H), 1.1–1.3 (m, 6H). MS (ESI) <i>m</i>/<i>z</i>: 511.5 [M + 1]<sup>+</sup>. Anal. Calcd for (%) C<sub>26</sub>H<sub>34</sub>N<sub>6</sub>O<sub>5</sub>·0.2H<sub>2</sub>O: C, 61.16; H, 6.71; N, 16.46. Found: C, 60.7; H, 6.43; N, 16.01.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-[(4<i>S</i>)-2,2-Dimethyltetrahydropyran-4-yl]oxy-<i>N</i>-[2-methoxy-4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl]-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>16</b>)</h4><div class="NLM_p last">Yield 3.78 g, 7.4 mmol, 74%, HPLC purity >99%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.38 (s, 1H), 8.30 (d, <i>J</i> = 8.8 Hz, 1H), 7.22 (s, 1H), 6.71–6.70 (m, 1H), 6.62 (d, <i>J</i> = 2.4 Hz, 1H), 6.40–6.39 (m, 1H), 5.68–5.60 (m, 1H), 4.76–4.69 (m, 4H), 3.99–3.83 (m, 5H), 3.61 (t, <i>J</i> = 6.4 Hz, 1H), 3.21 (t, <i>J</i> = 4.8 Hz, 4H), 2.56 (t, <i>J</i> = 5.2 Hz, 4H), 2.15–2.09 (m, 2H), 1.75–1.70 (m, 2H), 1.36 (d, <i>J</i> = 6.8 Hz, 6H). MS (ESI): 510.4 <i>m</i>/<i>z</i> [M + 1]<sup>+</sup>. Anal. Calcd for (%) C<sub>27</sub>H<sub>36</sub>N<sub>6</sub>O<sub>4</sub>·0.47H<sub>2</sub>O: C, 62.72; H, 7.20; N, 16.25. Found: C, 62.7; H, 6.92; N, 16.31.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 3-Ethoxy-4-((4-(((1s,4s)-4-hydroxy-4-methylcyclohexyl)oxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-<i>N</i>,<i>N</i>-dimethylbenzamide (<b>17</b>)</h4><div class="NLM_p last">Yield 0.126 g, 0.28 mmol, 34%, HPLC purity >99%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.46–11.58 (m, 1H), 8.48–8.61 (m, 1H), 7.54–7.62 (m, 1H), 6.93–7.10 (m, 3H), 6.28–6.35 (m, 1H), 5.06–5.20 (m, 1H), 4.21–4.25 (m, 1H), 4.12–4.21 (m, 2H), 2.89–3.05 (m, 6H), 1.79–1.94 (m, 4H), 1.59–1.72 (m, 2H), 1.45–1.54 (m, 2H), 1.33–1.45 (m, 3H), 1.09–1.21 (m, 3H). MS (ESI) <i>m</i>/<i>z</i>: 454.3 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-((4-(((1s,4s)-4-Hydroxy-4-methylcyclohexyl)oxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-<i>N</i>,<i>N</i>-dimethyl-3-(2,2,2-trifluoroethoxy)benzamide (<b>18</b>)</h4><div class="NLM_p last">Yield 0.076 g, 0.15 mmol, 52%, HPLC purity >99%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.42–11.63 (m, 1H), 8.47–8.57 (m, 1H), 7.50–7.63 (m, 1H), 7.22–7.31 (m, 1H), 7.09–7.15 (m, 1H), 6.98–7.06 (m, 1H), 6.29–6.41 (m, 1H), 5.05–5.20 (m, 1H), 4.84–4.98 (m, 2H), 4.15–4.24 (m, 1H), 2.99 (s, 6H), 1.80–1.97 (m, 4H), 1.60–1.71 (m, 2H), 1.40–1.52 (m, 2H), 1.17 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 508.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4-((4-(((1s,4s)-4-Hydroxy-4-methylcyclohexyl)oxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-<i>N</i>,<i>N</i>-dimethyl-3-(((<i>R</i>)-1,1,1-trifluoropropan-2-yl)oxy)benzamide (<b>19</b>)</h4><div class="NLM_p last">Yield 0.073 g, 0.14 mmol, 39% yield, HPLC purity >99%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.41–11.74 (m, 1H), 8.45–8.71 (m, 1H), 7.47–7.55 (m, 1H), 7.27–7.32 (m, 1H), 7.08–7.17 (m, 1H), 6.98–7.07 (m, 1H), 6.27–6.35 (m, 1H), 5.27–5.42 (m, 1H), 5.03–5.18 (m, 1H), 4.13–4.26 (m, 1H), 2.98 (s, 6H), 1.81–1.97 (m, 4H), 1.58–1.75 (m, 2H), 1.39–1.52 (m, 5H), 1.04–1.21 (m, 3H). MS (ESI) <i>m</i>/<i>z</i>: 522.2 [M + 1]<sup>+</sup>. Anal. Calcd for (%) C<sub>25</sub>H<sub>30</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub>: C, 57.57; H, 5.80; N, 13.43. Found: C, 57.28; H, 5.77; N, 13.37.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-[[5-Chloro-4-(4-hydroxy-4-methyl-cyclohexoxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]amino]-<i>N</i>,<i>N</i>-dimethyl-3-[(1<i>R</i>)-2,2,2-trifluoro-1-methyl-ethoxy]benzamide (<b>20</b>)</h4><div class="NLM_p last">Yield 3.44 g, 6.2 mmol, 47%, HPLC purity >99%. <sup>1</sup>H NMR (400 MHz DMSO-<i>d</i><sub>6</sub>): δ 11.74 (s, 1H), 8.42 (d, <i>J</i> = 8.4 Hz, 1H), 7.62 (s, 1H), 7.32 (s, 1H), 7.16–7.11 (m, 2H), 5.36–5.33 (m, 1H), 5.13 (s, 1H), 4.23 (s, 1H), 2.98 (s, 6H), 1.86–1.87 (m, 4H), 1.69–1.66 (m, 2H), 1.48–1.43 (m, 5H), 1.16 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 556.3 [M + 1]<sup>+</sup>. Anal. Calcd for (%) C<sub>25</sub>H<sub>29</sub>N<sub>5</sub>O<sub>4</sub>·0.5H<sub>2</sub>O: C, 53.68; H, 5.29; N, 12.52. Found: C, 53.49; H, 5.29; N, 12.24.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> In Vitro Kinase Selectivity Profiling</h3><div class="NLM_p last">The kinase selectivity profile of compound <b>20</b> was assessed at 3 μM against 255 kinases at Invitrogen using one of the following protocols: Z′-LYTE protocol, ADAPTA or the Lantha binding assay. The TTK binding affinity was measured at Invitrogen using the LanthaScreen Eu kinase binding assays. The LanthaScreen Eu kinase binding assays are based on the binding and displacement of a proprietary, Alexa Fluor 647-labeled, adenosine triphosphate -competitive kinase inhibitor scaffold (kinase tracer).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Immunoblot Analyses</h3><div class="NLM_p last">Cells were lysed in radioimmunoprecipitation assay buffer (Thermos Scientific, catalog # 89900). The protein concentration of the lysates was determined by the Bio-Rad protein assay (Bio-Rad, catalog # 500-0001). Thirty micrograms of protein from each lysate were loaded onto NuPAGE Novex 4–12% bis–Tris gels (Invitrogen #EA0375) and run in MES SDS running buffer. Protein was then transferred and blotted with primary antibodies. Primary antibodies used were as follows: phospho-TTK T686 (custom made rabbit monoclonal antibody) and <i>p</i>-KNL1 T943 (custom-made polyclonal antibody). Goat anti-rabbit Alexa Fluor680 (Invitrogen cat # A21076) and goat anti-mouse IRDye800 (Rockland Immunochemicals cat # 610-132-121) were then used to detect the protein bands. The membranes were scanned using the Odyssey infrared imaging system (LI-COR Biosciences).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Cellular Proliferation Assays</h3><div class="NLM_p last">CAL-51 was purchased from DSMZ. The cell line was maintained in growth media as recommended by the vendors. The cells were incubated with compound for 3 days. CellTiter-Glo reagent was added to each well, and the luminescence was measured on the EnVision Multilabel (PerkinElmer) plate reader. The percent inhibition at each compound concentration was determined by normalizing data to the DMSO control values for each set of triplicate wells. All data were analyzed using XLfit from IDBS. The formula used for determining IC<sub>50</sub> in XLfit was model number 205, which utilizes a 4-parameter logistic model or sigmoidal dose-response model to calculate IC<sub>50</sub> values. Full experimental details have been previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Crystallization</h3><div class="NLM_p">The TTK kinase domain with a thrombin-cleavable, N-terminal 6× His tag was expressed in <i>Escherichia coli</i> strain BL21(DE3) (Life Technologies). Cells were grown in LB media and induced for 4 h at 20 °C. Initial capture was performed via nickel affinity chromatography using nickel-NTA resin. The 6× His tag was cleaved by the addition of thrombin, and the protein passed back over nickel-NTA resin. Cleaved TTK was purified by S-75 size exclusion chromatography (GE Healthcare) and concentrated to 11 mg/mL. TTK was crystallized by sitting drop vapor diffusion at 4 °C in the presence of 1 mM of compound <b>20</b>. The TTK/<b>20</b> complex was mixed 1:1 with, and subsequently equilibrated against, a solution of 100 mM Tris pH 8.5, 300 mM sodium acetate, 8% PEG 20k, 8% PEG 500 MME. Crystals were cryo-protected by the addition of 20% ethylene glycol and flash cooled under liquid nitrogen.</div><div class="NLM_p last">Diffraction data was collected at the Canadian Light Source, beamline CMCF-08ID. Data were indexed, integrated, and scaled using HKL2000.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The structure was solved using PHASER molecular replacement.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Manual model building was performed using COOT and refined using CCP4.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> Coordinates and structure factors have been deposited in the Protein Data Bank with the accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N6O">6N6O</a>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Computational Methods and Modeling</h3><div class="NLM_p last">The Schrödinger Small-Molecule Drug Discovery Suite was used for small molecule–protein and crystal structure visualization and analysis. Maestro: Schrödinger Release 2017-1: MS Jaguar, S., LLC, New York, NY, 2017. The <a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">Supporting Information</a> contains additional modeling studies.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> In Vivo Studies</h3><div class="NLM_p">All animal studies were performed under protocols approved by the Celgene Institutional Animal Care and Use Committee (IACUC). Animals were acclimatized to the animal housing facility for a period of 7 days prior to the beginning of the experiment. Female 6–8 weeks old CB17 SCID (severe combined immunodeficiency) (Charles River Laboratories) mice were housed in a barrier facility in micro-isolator cages at 10 animals per cage. Mice were fed with Harlan Teklad LM-485 mouse/rat sterilizable diet and autoclaved water ad libitum and maintained on a 12 h light/dark cycle.</div><div class="NLM_p">SCID mice were inoculated subcutaneously with 2 × 10<sup>6</sup> CAL-51 cells. Tumor volumes were determined prior to the initiation of treatment and considered as the starting volumes. Tumors were measured twice a week for the duration of the study. The long and short axes of each tumor were measured using a digital caliper in millimeters. The tumor volumes were calculated using the formula: width<sup>2</sup> × length/2. The tumor volumes were expressed in cubic millimeters (mm<sup>3</sup>).</div><div class="NLM_p">Mechanism of action studies were done with mice bearing CAL-51 tumors ranging from 300 to 500 mm<sup>3</sup>. At predetermined time points after compound administration, the mice were euthanized, and the tumors were dissected and snap frozen in liquid nitrogen MSD assays. MSD electrochemiluminescent immunoassay kits and protocol were used for measuring the pHH3 Ser10 and cleaved caspase.</div><div class="NLM_p last">Xenograft and in vivo biomarker data are expressed as mean ± standard error of the mean (SEM). Statistical analyses were performed using GraphPad Prism. A one-way analysis of variance (ANOVA) was performed for tumor volume and PD marker measurements. Post hoc analysis was performed using Dunnett’s test where all treatment groups are compared with the vehicle control.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01869" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37165" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37165" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01869" class="ext-link">10.1021/acs.jmedchem.8b01869</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Rat PO PK for compound <b>1</b>, averages and SEM values for potency and PK data, in vitro kinase selectivity data for compound <b>20</b>, additional TTK crystal structure views, BWL graph for xenograft study, and experimental procedures for intermediates (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf">jm8b01869_si_001.pdf (411.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_002.csv">jm8b01869_si_002.csv (1.74 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01869" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer R. Riggs</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9012-1428" title="Orcid link">http://orcid.org/0000-0001-9012-1428</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#85eff7ece2e2f6c5e6e0e9e2e0ebe0abe6eae8"><span class="__cf_email__" data-cfemail="cca6bea5ababbf8cafa9a0aba9a2a9e2afa3a1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Elsner</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Cashion</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dale Robinson</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lida Tehrani</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Nagy</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly E. Fultz</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rama Krishna Narla</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaohui Peng</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tam Tran</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashutosh Kulkarni</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sogole Bahmanyar</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Condroski</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5801-9332" title="Orcid link">http://orcid.org/0000-0002-5801-9332</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbra Pagarigan</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gustavo Fenalti</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurie LeBrun</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katerina Leftheris</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Zhu</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John F. Boylan</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors are employees of Celgene, except K.E.F., A.K., K.C., and K.L., who were Celgene employees at the time of their contribution to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank the Celgene San Diego DMPK department for analysis, the Celgene San Diego analytical and compound management groups for project support, Deborah Mortensen for editorial comments and helpful discussions, and Lawrence Hamann and Jorge DiMartino for project guidance. Crystal structure determination was performed at the Canadian Light Source using beamline 08ID-1. The Canadian Light Source is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, Western Economic Diversification Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the University of Saskatchewan, and the Government of Saskatchewan.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple negative breast cancer</p></td></tr><tr><td class="NLM_term">Mps1</td><td class="NLM_def"><p class="first last">monopolar spindle 1</p></td></tr><tr><td class="NLM_term">CLK2</td><td class="NLM_def"><p class="first last">CDC2-like kinase</p></td></tr><tr><td class="NLM_term">SAC</td><td class="NLM_def"><p class="first last">spindle assembly checkpoint</p></td></tr><tr><td class="NLM_term">KNL1</td><td class="NLM_def"><p class="first last">kinetochore scaffold 1</p></td></tr><tr><td class="NLM_term">LRRK2</td><td class="NLM_def"><p class="first last">Leucine-rich repeat kinase 2</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">DYRK3</td><td class="NLM_def"><p class="first last">dual specificity tyrosine-phosphorylation-regulated kinase 3</p></td></tr><tr><td class="NLM_term">TSSK</td><td class="NLM_def"><p class="first last">testis-specific serine/threonine-protein kinase 2</p></td></tr><tr><td class="NLM_term">Ltk</td><td class="NLM_def"><p class="first last">leukocyte receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">BWL</td><td class="NLM_def"><p class="first last">body weight loss</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cashion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deyanat-Yazdi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moghaddam, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahmanyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagarigan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBrun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leftheris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boylan, J. F.</span></span> <span> </span><span class="NLM_article-title">The discovery of a dual TTK protein kinase/CDC2-like kinase (CLK2) inhibitor for the treatment of triple negative breast cancer initiated from a phenotypic screen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8989</span>– <span class="NLM_lpage">9002</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01223</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01223" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1amu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8989-9002&author=J.+R.+Riggsauthor=M.+Nagyauthor=J.+Elsnerauthor=P.+Erdmanauthor=D.+Cashionauthor=D.+Robinsonauthor=R.+Harrisauthor=D.+Huangauthor=L.+Tehraniauthor=G.+Deyanat-Yazdiauthor=R.+K.+Narlaauthor=X.+Pengauthor=T.+Tranauthor=L.+Barnesauthor=T.+Millerauthor=J.+Katzauthor=Y.+Tangauthor=M.+Chenauthor=M.+F.+Moghaddamauthor=S.+Bahmanyarauthor=B.+Pagariganauthor=S.+Delkerauthor=L.+LeBrunauthor=P.+P.+Chamberlainauthor=A.+Calabreseauthor=S.+S.+Cananauthor=K.+Leftherisauthor=D.+Zhuauthor=J.+F.+Boylan&title=The+discovery+of+a+dual+TTK+protein+kinase%2FCDC2-like+kinase+%28CLK2%29+inhibitor+for+the+treatment+of+triple+negative+breast+cancer+initiated+from+a+phenotypic+screen&doi=10.1021%2Facs.jmedchem.7b01223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen</span></div><div class="casAuthors">Riggs, Jennifer R.; Nagy, Mark; Elsner, Jan; Erdman, Paul; Cashion, Dan; Robinson, Dale; Harris, Roy; Huang, Dehua; Tehrani, Lida; Deyanat-Yazdi, Gordafaried; Narla, Rama Krishna; Peng, Xiaohui; Tran, Tam; Barnes, Leo; Miller, Terra; Katz, Jason; Tang, Yang; Chen, Ming; Moghaddam, Mehran F.; Bahmanyar, Sogole; Pagarigan, Barbra; Delker, Silvia; LeBrun, Laurie; Chamberlain, Philip P.; Calabrese, Andrew; Canan, Stacie S.; Leftheris, Katerina; Zhu, Dan; Boylan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8989-9002</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Triple neg. breast cancer (TNBC) remains a serious unmet medical need with discouragingly high relapse rates.  The authors report here the synthesis and structure-activity relationship (SAR) of a novel series of 2,4,5-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines with potent activity against TNBC tumor cell lines.  These compds. were discovered from a TNBC phenotypic screen and possess a unique dual inhibition profile targeting TTK (mitotic exit) and CLK2 (mRNA splicing).  Design and optimization, driven with a TNBC tumor cell assay, identified potent and selective compds. with favorable in vitro and in vivo activity profiles and good iv PK properties.  This cell-based driven SAR produced compds. with strong single agent in vivo efficacy in multiple TNBC xenograft models without significant body wt. loss.  These data supported the nomination of CC-671 (compd. I) into IND-enabling studies as a single agent TNBC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZC5zKGXAFFLVg90H21EOLACvtfcHk0li6j--_fqKVIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1amu77E&md5=0e55c6e9ad0e57dd189cccfd19b574bc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01223%26sid%3Dliteratum%253Aachs%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DNagy%26aufirst%3DM.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DErdman%26aufirst%3DP.%26aulast%3DCashion%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DDeyanat-Yazdi%26aufirst%3DG.%26aulast%3DNarla%26aufirst%3DR.%2BK.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DBarnes%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DMoghaddam%26aufirst%3DM.%2BF.%26aulast%3DBahmanyar%26aufirst%3DS.%26aulast%3DPagarigan%26aufirst%3DB.%26aulast%3DDelker%26aufirst%3DS.%26aulast%3DLeBrun%26aufirst%3DL.%26aulast%3DChamberlain%26aufirst%3DP.%2BP.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DCanan%26aufirst%3DS.%2BS.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520discovery%2520of%2520a%2520dual%2520TTK%2520protein%2520kinase%252FCDC2-like%2520kinase%2520%2528CLK2%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520triple%2520negative%2520breast%2520cancer%2520initiated%2520from%2520a%2520phenotypic%2520screen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8989%26epage%3D9002%26doi%3D10.1021%2Facs.jmedchem.7b01223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deyanat-Yazdi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikolon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymon, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boylan, J. F.</span></span> <span> </span><span class="NLM_article-title">Synthetic lethal strategy identifies a potent and selective TTK and CLK1/2 inhibitor for treatment of triple-negative breast cancer with a compromised G1-S checkpoint</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1727</span>– <span class="NLM_lpage">1738</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-17-1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1158%2F1535-7163.mct-17-1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=29866747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWrtrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1727-1738&author=D.+Zhuauthor=S.+Xuauthor=G.+Deyanat-Yazdiauthor=S.+X.+Pengauthor=L.+A.+Barnesauthor=R.+K.+Narlaauthor=T.+Tranauthor=D.+Mikolonauthor=Y.+Ningauthor=T.+Shiauthor=N.+Jiangauthor=H.+K.+Raymonauthor=J.+R.+Riggsauthor=J.+F.+Boylan&title=Synthetic+lethal+strategy+identifies+a+potent+and+selective+TTK+and+CLK1%2F2+inhibitor+for+treatment+of+triple-negative+breast+cancer+with+a+compromised+G1-S+checkpoint&doi=10.1158%2F1535-7163.mct-17-1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK1/2 Inhibitor for Treatment of Triple-Negative Breast Cancer with a Compromised G1-S Checkpoint</span></div><div class="casAuthors">Zhu, Dan; Xu, Shuichan; Deyanat-Yazdi, Gordafaried; Peng, Sophie X.; Barnes, Leo A.; Narla, Rama Krishna; Tran, Tam; Mikolon, David; Ning, Yuhong; Shi, Tao; Jiang, Ning; Raymon, Heather K.; Riggs, Jennifer R.; Boylan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1727-1738</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Historically, phenotypic-based drug discovery has yielded a high percentage of novel drugs while uncovering new tumor biol.  CC-671 was discovered using a phenotypic screen for compds. that preferentially induced apoptosis in triple-neg. breast cancer cell lines while sparing luminal breast cancer cell lines.  Detailed in vitro kinase profiling shows CC-671 potently and selectively inhibits two kinases-TTK and CLK2.  Cellular mechanism of action studies demonstrate that CC-671 potently inhibits the phosphorylation of KNL1 and SRp75, direct TTK and CLK2 substrates, resp.  Furthermore, CC-671 causes mitotic acceleration and modification of pre-mRNA splicing leading to apoptosis, consistent with cellular TTK and CLK inhibition.  Correlative anal. of genomic and potency data against a large panel of breast cancer cell lines identifies breast cancer cells with a dysfunctional G1-S checkpoint as more sensitive to CC-671, suggesting synthetic lethality between G1-S checkpoint and TTK/CLK2 inhibition.  Furthermore, significant in vivo CC-671 efficacy was demonstrated in two cell line-derived and one patient tumor-derived xenograft models of triple-neg. breast cancer (TNBC) following weekly dosing.  These findings are the first to demonstrate the unique inhibitory combination activity of a dual TTK/CLK2 inhibitor that preferably kills TNBC cells and shows synthetic lethality with a compromised G1-S checkpoint in breast cancer cell lines.  On the basis of these data, CC-671 was moved forward for clin. development as a potent and selective TTK/CLK2 inhibitor in a subset of patients with TNBC.  Mol Cancer Ther; 17(8); 1727-38. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolp4FNUUf1V7Vg90H21EOLACvtfcHk0lgatEdRG1HtsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWrtrbF&md5=1def06e14a8e056582ea792b37b26f6a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-17-1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-17-1084%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DDeyanat-Yazdi%26aufirst%3DG.%26aulast%3DPeng%26aufirst%3DS.%2BX.%26aulast%3DBarnes%26aufirst%3DL.%2BA.%26aulast%3DNarla%26aufirst%3DR.%2BK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DMikolon%26aufirst%3DD.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DRaymon%26aufirst%3DH.%2BK.%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26atitle%3DSynthetic%2520lethal%2520strategy%2520identifies%2520a%2520potent%2520and%2520selective%2520TTK%2520and%2520CLK1%252F2%2520inhibitor%2520for%2520treatment%2520of%2520triple-negative%2520breast%2520cancer%2520with%2520a%2520compromised%2520G1-S%2520checkpoint%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D1727%26epage%3D1738%26doi%3D10.1158%2F1535-7163.mct-17-1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiruma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacristan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachis, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuijt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubbink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Castelmur, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kops, G. J. P. L.</span></span> <span> </span><span class="NLM_article-title">Competition between MPS1 and microtubules at kinetochores regulates spindle checkpoint signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">1264</span>– <span class="NLM_lpage">1267</span>, <span class="refDoi"> DOI: 10.1126/science.aaa4055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1126%2Fscience.aaa4055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=26068855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps1Oltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2015&pages=1264-1267&author=Y.+Hirumaauthor=C.+Sacristanauthor=S.+T.+Pachisauthor=A.+Adamopoulosauthor=T.+Kuijtauthor=M.+Ubbinkauthor=E.+von+Castelmurauthor=A.+Perrakisauthor=G.+J.+P.+L.+Kops&title=Competition+between+MPS1+and+microtubules+at+kinetochores+regulates+spindle+checkpoint+signaling&doi=10.1126%2Fscience.aaa4055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Competition between MPS1 and microtubules at kinetochores regulates spindle checkpoint signaling</span></div><div class="casAuthors">Hiruma, Yoshitaka; Sacristan, Carlos; Pachis, Spyridon T.; Adamopoulos, Athanassios; Kuijt, Timo; Ubbink, Marcellus; von Castelmur, Eleonore; Perrakis, Anastassis; Kops, Geert J. P. L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6240</span>),
    <span class="NLM_cas:pages">1264-1267</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cell division progresses to anaphase only after all chromosomes are connected to spindle microtubules through kinetochores and the spindle assembly checkpoint (SAC) is satisfied.  Here, the authors show that the N-terminal localization module of SAC protein kinase MPS1 (monopolar spindle 1) directly interacts with the HEC1 (highly expressed in cancer 1) calponin homol. domain in the NDC80 (nuclear division cycle 80) kinetochore complex in vitro, in a phosphorylation-dependent manner.  Microtubule polymers disrupted this interaction.  In cells, MPS1 binding to kinetochores or to ectopic NDC80 complexes was prevented by end-on microtubule attachment, independent of known kinetochore protein-removal mechanisms.  Competition for kinetochore binding between SAC proteins and microtubules provides a direct and perhaps evolutionarily conserved way to detect a properly organized spindle ready for cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof51pqHltOW7Vg90H21EOLACvtfcHk0lgatEdRG1HtsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps1Oltb8%253D&md5=378c8e3c2fea7c70c1caeaa69dfd3f8f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaa4055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaa4055%26sid%3Dliteratum%253Aachs%26aulast%3DHiruma%26aufirst%3DY.%26aulast%3DSacristan%26aufirst%3DC.%26aulast%3DPachis%26aufirst%3DS.%2BT.%26aulast%3DAdamopoulos%26aufirst%3DA.%26aulast%3DKuijt%26aufirst%3DT.%26aulast%3DUbbink%26aufirst%3DM.%26aulast%3Dvon%2BCastelmur%26aufirst%3DE.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26atitle%3DCompetition%2520between%2520MPS1%2520and%2520microtubules%2520at%2520kinetochores%2520regulates%2520spindle%2520checkpoint%2520signaling%26jtitle%3DScience%26date%3D2015%26volume%3D348%26spage%3D1264%26epage%3D1267%26doi%3D10.1126%2Fscience.aaa4055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kops, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, R. H.</span></span> <span> </span><span class="NLM_article-title">Targeting the mitotic checkpoint to kill tumor cells</span>. <i>Horm. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1007/s12672-010-0059-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1007%2Fs12672-010-0059-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=21475725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnot1Wkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=113-116&author=A.+Janssenauthor=G.+J.+Kopsauthor=R.+H.+Medema&title=Targeting+the+mitotic+checkpoint+to+kill+tumor+cells&doi=10.1007%2Fs12672-010-0059-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the mitotic checkpoint to kill tumor cells</span></div><div class="casAuthors">Janssen Aniek; Kops Geert J; Medema Rene H</div><div class="citationInfo"><span class="NLM_cas:title">Hormones & cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">One of the most common hallmarks of cancer cells is aneuploidy or an abnormal number of chromosomes.  This abnormal chromosome content is a consequence of chromosome missegregation during mitosis, a defect that is seen more frequently in tumor cell divisions as in normal cell divisions.  In fact, a large fraction of human tumors display a chromosome instable phenotype, meaning that they very frequently missegregate chromosomes.  This can cause variegated aneuploidy within the tumor tissue.  It has been argued that this hallmark of cancer could be exploited in anti-cancer therapies.  Here we test this hypothesis by inactivation of the mitotic checkpoint through RNAi-mediated depletion of an essential checkpoint component, Mps1.  The mitotic checkpoint delays segregation of chromosomes during mitosis until all chromosomes are properly attached to the mitotic spindle.  Its inactivation will therefore lead to increased segregation errors.  Indeed, we show that this can lead to increased cell death in tumor cells.  We demonstrate that increased cell death is associated with a dramatic increase in segregation errors.  This suggests that inhibition of the mitotic checkpoint might represent a useful anti-cancer strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTx5ZlxKChceNts4TFFB11gfW6udTcc2eadOwQ2XdY9Irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnot1Wkug%253D%253D&md5=7ea1be16c9e26670ce447b0caca260c3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs12672-010-0059-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12672-010-0059-x%26sid%3Dliteratum%253Aachs%26aulast%3DJanssen%26aufirst%3DA.%26aulast%3DKops%26aufirst%3DG.%2BJ.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26atitle%3DTargeting%2520the%2520mitotic%2520checkpoint%2520to%2520kill%2520tumor%2520cells%26jtitle%3DHorm.%2520Cancer%26date%3D2011%26volume%3D2%26spage%3D113%26epage%3D116%26doi%3D10.1007%2Fs12672-010-0059-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennecozzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgini, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappella, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depaolini, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchi, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avanzi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossi, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesenti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, J.</span></span> <span> </span><span class="NLM_article-title">Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">10255</span>– <span class="NLM_lpage">10264</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-10-2101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1158%2F0008-5472.can-10-2101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10255-10264&author=R.+Colomboauthor=M.+Caldarelliauthor=M.+Mennecozziauthor=M.+L.+Giorginiauthor=F.+Solaauthor=P.+Cappellaauthor=C.+Perreraauthor=S.+R.+Depaoliniauthor=L.+Rusconiauthor=U.+Cucchiauthor=N.+Avanziauthor=J.+A.+Bertrandauthor=R.+T.+Bossiauthor=E.+Pesentiauthor=A.+Galvaniauthor=A.+Isacchiauthor=F.+Colottaauthor=D.+Donatiauthor=J.+Moll&title=Targeting+the+mitotic+checkpoint+for+cancer+therapy+with+NMS-P715%2C+an+inhibitor+of+MPS1+kinase&doi=10.1158%2F0008-5472.can-10-2101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-10-2101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-10-2101%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DCaldarelli%26aufirst%3DM.%26aulast%3DMennecozzi%26aufirst%3DM.%26aulast%3DGiorgini%26aufirst%3DM.%2BL.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DCappella%26aufirst%3DP.%26aulast%3DPerrera%26aufirst%3DC.%26aulast%3DDepaolini%26aufirst%3DS.%2BR.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DCucchi%26aufirst%3DU.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DColotta%26aufirst%3DF.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DMoll%26aufirst%3DJ.%26atitle%3DTargeting%2520the%2520mitotic%2520checkpoint%2520for%2520cancer%2520therapy%2520with%2520NMS-P715%252C%2520an%2520inhibitor%2520of%2520MPS1%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D10255%26epage%3D10264%26doi%3D10.1158%2F0008-5472.can-10-2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maire, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldeyron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent-Salomon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty-Prouvost, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Koning, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigaill, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentien, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barillot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman-Roman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzalegui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierré, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, T.</span></span> <span> </span><span class="NLM_article-title">TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e63712</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0063712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1371%2Fjournal.pone.0063712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=23700430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslamtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=V.+Maireauthor=C.+Baldeyronauthor=M.+Richardsonauthor=B.+Tessonauthor=A.+Vincent-Salomonauthor=E.+Gravierauthor=B.+Marty-Prouvostauthor=L.+De+Koningauthor=G.+Rigaillauthor=A.+Dumontauthor=D.+Gentienauthor=E.+Barillotauthor=S.+Roman-Romanauthor=S.+Depilauthor=F.+Cruzaleguiauthor=A.+Pierr%C3%A9author=G.+C.+Tuckerauthor=T.+Dubois&title=TTK%2FhMPS1+is+an+attractive+therapeutic+target+for+triple-negative+breast+cancer&doi=10.1371%2Fjournal.pone.0063712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer</span></div><div class="casAuthors">Maire, Virginie; Baldeyron, Celine; Richardson, Marion; Tesson, Bruno; Vincent-Salomon, Anne; Gravier, Eleonore; Marty-Prouvost, Berengere; De Koning, Leanne; Rigaill, Guillem; Dumont, Aurelie; Gentien, David; Barillot, Emmanuel; Roman-Roman, Sergio; Depil, Stephane; Cruzalegui, Francisco; Pierre, Alain; Tucker, Gordon C.; Dubois, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e63712</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) represents a subgroup of breast cancers (BC) assocd. with the most aggressive clin. behavior.  No targeted therapy is currently available for the treatment of patients with TNBC.  In order to discover potential therapeutic targets, we searched for protein kinases that are overexpressed in human TNBC biopsies and whose silencing in TNBC cell lines causes cell death.  A cohort including human BC biopsies obtained at Institut Curie as well as normal tissues has been analyzed at a gene-expression level.  The data revealed that the human protein kinase monopolar spindle 1 (hMPS1), also known as TTK and involved in mitotic checkpoint, is specifically overexpressed in TNBC, compared to the other BC subgroups and healthy tissues.  We confirmed by immunohistochem. and reverse phase protein array that TNBC expressed higher levels of TTK protein compared to the other BC subgroups.  We then detd. the biol. effects of TTK depletion by RNA interference, through analyses of tumorigenic capacity and cell viability in different human TNBC cell lines.  We found that RNAi-mediated depletion of TTK in various TNBC cell lines severely compromised their viability and their ability to form colonies in an anchorage-independent manner.  Moreover, we obsd. that TTK silencing led to an increase in H2AX phosphorylation, activation of caspases 3/7, sub-G1 cell population accumulation and high annexin V staining, as well as to a decrease in G1 phase cell population and an increased aneuploidy.  Altogether, these data indicate that TTK depletion in TNBC cells induces apoptosis.  These results point out TTK as a protein kinase overexpressed in TNBC that may represent an attractive therapeutic target specifically for this poor prognosis assocd. subgroup of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCemS4PKt5pLVg90H21EOLACvtfcHk0lgRzIAQV8dkow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslamtrs%253D&md5=21e30c2ca30b75839c07e13cdd19d897</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0063712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0063712%26sid%3Dliteratum%253Aachs%26aulast%3DMaire%26aufirst%3DV.%26aulast%3DBaldeyron%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DM.%26aulast%3DTesson%26aufirst%3DB.%26aulast%3DVincent-Salomon%26aufirst%3DA.%26aulast%3DGravier%26aufirst%3DE.%26aulast%3DMarty-Prouvost%26aufirst%3DB.%26aulast%3DDe%2BKoning%26aufirst%3DL.%26aulast%3DRigaill%26aufirst%3DG.%26aulast%3DDumont%26aufirst%3DA.%26aulast%3DGentien%26aufirst%3DD.%26aulast%3DBarillot%26aufirst%3DE.%26aulast%3DRoman-Roman%26aufirst%3DS.%26aulast%3DDepil%26aufirst%3DS.%26aulast%3DCruzalegui%26aufirst%3DF.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DTucker%26aufirst%3DG.%2BC.%26aulast%3DDubois%26aufirst%3DT.%26atitle%3DTTK%252FhMPS1%2520is%2520an%2520attractive%2520therapeutic%2520target%2520for%2520triple-negative%2520breast%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0063712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awrey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeira, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)benzamides as novel, highly potent and selective, orally bioavailable inhibitors of tyrosine threonine kinase, TTK</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3562</span>– <span class="NLM_lpage">3566</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1016%2Fj.bmcl.2016.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=27335255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKgtLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3562-3566&author=R.+Lauferauthor=S.-W.+Liauthor=Y.+Liuauthor=G.+Ngauthor=Y.+Langauthor=M.+Feherauthor=R.+Brokxauthor=I.+Beletskayaauthor=R.+Hodgsonauthor=G.+Maoauthor=O.+Plotnikovaauthor=D.+E.+Awreyauthor=J.+M.+Masonauthor=X.+Weiauthor=D.+C.-C.+Linauthor=Y.+Cheauthor=R.+Kiarashauthor=B.+Madeiraauthor=G.+C.+Fletcherauthor=T.+W.+Makauthor=M.+R.+Brayauthor=H.+W.+Pauls&title=Discovery+of+4-%284-aminopyrazolo%5B1%2C5-a%5D%5B1%2C3%2C5%5Dtriazin-8-yl%29benzamides+as+novel%2C+highly+potent+and+selective%2C+orally+bioavailable+inhibitors+of+tyrosine+threonine+kinase%2C+TTK&doi=10.1016%2Fj.bmcl.2016.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)benzamides as novel, highly potent and selective, orally bioavailable inhibitors of Tyrosine Threonine Kinase, TTK</span></div><div class="casAuthors">Laufer, Radoslaw; Li, Sze-Wan; Liu, Yong; Ng, Grace; Lang, Yunhui; Feher, Miklos; Brokx, Richard; Beletskaya, Irina; Hodgson, Richard; Mao, Guodong; Plotnikova, Olga; Awrey, Donald E.; Mason, Jacqueline M.; Wei, Xin; Lin, Dan Chi-Chia; Che, Yi; Kiarash, Reza; Madeira, Brian; Fletcher, Graham C.; Mak, Tak W.; Bray, Mark R.; Pauls, Henry W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3562-3566</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">TTK/Mps1 is a key kinase controlling progression of cell division via participation in the mitotic spindle assembly checkpoint and is overexpressed in a no. of human cancers.  Herein the authors report the discovery of 4-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)benzamides as a potent, novel class of TTK inhibitors.  The series was identified by bioisosteric replacement of the related imidazopyrazine and imidazopyridazine scaffolds.  Optimization led to the identification of compds. with excellent potency (Ki = 0.8 nM) and exceptional kinase selectivity.  The SAR indicates a strong dependence of activity on the presence of the N-cyclopropyl-2-methylbenzamide moiety delineating the geometry for 11/2 type kinase inhibitor.  Mol. modeling indicates the extensive and optimal contacts, mediated through H-bonds and hydrophobic interactions, are responsible for the selectivity and potency of the inhibitors.  The compds. demonstrate a strong anti-proliferative activity in a panel of human cancer cell lines (HCT116 GIC50 <15 nM) and good rodent pharmacokinetics (oral %F 97%).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTb2Z2xtkAWLVg90H21EOLACvtfcHk0lgRzIAQV8dkow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKgtLnL&md5=d107d562ed4407d05bfbba57abcd6b98</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBrokx%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DMadeira%26aufirst%3DB.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%25204-%25284-aminopyrazolo%255B1%252C5-a%255D%255B1%252C3%252C5%255Dtriazin-8-yl%2529benzamides%2520as%2520novel%252C%2520highly%2520potent%2520and%2520selective%252C%2520orally%2520bioavailable%2520inhibitors%2520of%2520tyrosine%2520threonine%2520kinase%252C%2520TTK%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3562%26epage%3D3566%26doi%3D10.1016%2Fj.bmcl.2016.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awrey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris-Brandts, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadeem, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirgadze, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4968</span>– <span class="NLM_lpage">4997</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1016%2Fj.bmc.2014.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=25043312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyjt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4968-4997&author=R.+Lauferauthor=G.+Ngauthor=Y.+Liuauthor=N.+K.+B.+Patelauthor=L.+G.+Edwardsauthor=Y.+Langauthor=S.-W.+Liauthor=M.+Feherauthor=D.+E.+Awreyauthor=G.+Leungauthor=I.+Beletskayaauthor=O.+Plotnikovaauthor=J.+M.+Masonauthor=R.+Hodgsonauthor=X.+Weiauthor=G.+Maoauthor=X.+Luoauthor=P.+Huangauthor=E.+Greenauthor=R.+Kiarashauthor=D.+C.-C.+Linauthor=M.+Harris-Brandtsauthor=F.+Banauthor=V.+Nadeemauthor=T.+W.+Makauthor=G.+J.+Panauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=H.+W.+Pauls&title=Discovery+of+inhibitors+of+the+mitotic+kinase+TTK+based+on+N-%283-%283-sulfamoylphenyl%29-1H-indazol-5-yl%29-acetamides+and+carboxamides&doi=10.1016%2Fj.bmc.2014.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)acetamides and carboxamides</span></div><div class="casAuthors">Laufer, Radoslaw; Ng, Grace; Liu, Yong; Patel, Narendra Kumar B.; Edwards, Louise G.; Lang, Yunhui; Li, Sze-Wan; Feher, Miklos; Awrey, Don E.; Leung, Genie; Beletskaya, Irina; Plotnikova, Olga; Mason, Jacqueline M.; Hodgson, Richard; Wei, Xin; Mao, Guodong; Luo, Xunyi; Huang, Ping; Green, Erin; Kiarash, Reza; Lin, Dan Chi-Chia; Harris-Brandts, Marees; Ban, Fuqiang; Nadeem, Vincent; Mak, Tak W.; Pan, Guohua J.; Qiu, Wei; Chirgadze, Nickolay Y.; Pauls, Henry W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4968-4997</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">TTK kinase was identified by inhouse siRNA screen and pursued as a tractable, novel target for cancer treatment.  A screening campaign and systematic optimization, supported by computer modeling led to an indazole core with key sulfamoylphenyl and acetamido moieties at positions 3 and 5, resp., establishing a novel chem. class culminating in identification of I (CFI-400936).  This potent inhibitor of TTK (IC50 = 3.6 nM) demonstrated good activity in cell based assay and selectivity against a panel of human kinases.  A complex TTK x-ray crystal structure and results of a xenograft study with TTK inhibitors from this class are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYMVdifCP5IrVg90H21EOLACvtfcHk0ljBrzwyKYwTTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyjt7fK&md5=71dac8de6f21ee67d1c18fd4e521a4f9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%2BB.%26aulast%3DEdwards%26aufirst%3DL.%2BG.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DHarris-Brandts%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DG.%2BJ.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%2520inhibitors%2520of%2520the%2520mitotic%2520kinase%2520TTK%2520based%2520on%2520N-%25283-%25283-sulfamoylphenyl%2529-1H-indazol-5-yl%2529-acetamides%2520and%2520carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4968%26epage%3D4997%26doi%3D10.1016%2Fj.bmc.2014.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awrey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirgadze, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeira, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">The discovery of orally bioavailable tyrosine threonine kinase (TTK) inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3366</span>– <span class="NLM_lpage">3392</span>, <span class="refDoi"> DOI: 10.1021/jm501740a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501740a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3366-3392&author=Y.+Liuauthor=Y.+Langauthor=N.+K.+Patelauthor=G.+Ngauthor=R.+Lauferauthor=S.-W.+Liauthor=L.+Edwardsauthor=B.+Forrestauthor=P.+B.+Sampsonauthor=M.+Feherauthor=F.+Banauthor=D.+E.+Awreyauthor=I.+Beletskayaauthor=G.+Maoauthor=R.+Hodgsonauthor=O.+Plotnikovaauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=J.+M.+Masonauthor=X.+Weiauthor=D.+C.-C.+Linauthor=Y.+Cheauthor=R.+Kiarashauthor=B.+Madeiraauthor=G.+C.+Fletcherauthor=T.+W.+Makauthor=M.+R.+Brayauthor=H.+W.+Pauls&title=The+discovery+of+orally+bioavailable+tyrosine+threonine+kinase+%28TTK%29+inhibitors%3A+3-%284-%28heterocyclyl%29phenyl%29-1H-indazole-5-carboxamides+as+anticancer+agents&doi=10.1021%2Fjm501740a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm501740a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501740a%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DForrest%26aufirst%3DB.%26aulast%3DSampson%26aufirst%3DP.%2BB.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DMadeira%26aufirst%3DB.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520orally%2520bioavailable%2520tyrosine%2520threonine%2520kinase%2520%2528TTK%2529%2520inhibitors%253A%25203-%25284-%2528heterocyclyl%2529phenyl%2529-1H-indazole-5-carboxamides%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3366%26epage%3D3392%26doi%3D10.1021%2Fjm501740a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awrey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirgadze, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyrazolo[1,5-a]pyrimidine TTK inhibitors: CFI-402257 is a potent, selective, bioavailable anticancer agent</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">675</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00485</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC28Xntl2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=671-675&author=Y.+Liuauthor=R.+Lauferauthor=N.+K.+Patelauthor=G.+Ngauthor=P.+B.+Sampsonauthor=S.-W.+Liauthor=Y.+Langauthor=M.+Feherauthor=R.+Brokxauthor=I.+Beletskayaauthor=R.+Hodgsonauthor=O.+Plotnikovaauthor=D.+E.+Awreyauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=J.+M.+Masonauthor=X.+Weiauthor=D.+C.-C.+Linauthor=Y.+Cheauthor=R.+Kiarashauthor=G.+C.+Fletcherauthor=T.+W.+Makauthor=M.+R.+Brayauthor=H.+W.+Pauls&title=Discovery+of+pyrazolo%5B1%2C5-a%5Dpyrimidine+TTK+inhibitors%3A+CFI-402257+is+a+potent%2C+selective%2C+bioavailable+anticancer+agent&doi=10.1021%2Facsmedchemlett.5b00485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyrazolo[1,5-a]pyrimidine TTK Inhibitors: CFI-402257 is a Potent, Selective, Bioavailable Anticancer Agent</span></div><div class="casAuthors">Liu, Yong; Laufer, Radoslaw; Patel, Narendra Kumar; Ng, Grace; Sampson, Peter B.; Li, Sze-Wan; Lang, Yunhui; Feher, Miklos; Brokx, Richard; Beletskaya, Irina; Hodgson, Richard; Plotnikova, Olga; Awrey, Donald E.; Qiu, Wei; Chirgadze, Nickolay Y.; Mason, Jacqueline M.; Wei, Xin; Lin, Dan Chi-Chia; Che, Yi; Kiarash, Reza; Fletcher, Graham C.; Mak, Tak W.; Bray, Mark R.; Pauls, Henry W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">671-675</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work describes a scaffold hopping exercise that begins with known imidazo[1,2-a]pyrazines, briefly explores pyrazolo[1,5-a][1,3,5]triazines, and ultimately yields pyrazolo[1,5-a]pyrimidines as a novel class of potent TTK inhibitors.  An X-ray structure of a representative compd. is consistent with 11/2 type inhibition and provides structural insight to aid subsequent optimization of in vitro activity and physicochem. and pharmacokinetic properties.  Incorporation of polar moieties in the hydrophobic and solvent accessible regions modulates physicochem. properties while maintaining potency.  Compds. with enhanced oral exposure were identified for xenograft studies.  The work culminates in the identification of a potent (TTK Ki = 0.1 nM), highly selective, orally bioavailable anticancer agent (CFI-402257) for IND enabling studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YPAge-MdqLVg90H21EOLACvtfcHk0li0lkc5XDFyKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xntl2isLo%253D&md5=3eb4e1971e0c0a73e6eee657ac9d6fe0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00485%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DN.%2BK.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DSampson%26aufirst%3DP.%2BB.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBrokx%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520TTK%2520inhibitors%253A%2520CFI-402257%2520is%2520a%2520potent%252C%2520selective%252C%2520bioavailable%2520anticancer%2520agent%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D671%26epage%3D675%26doi%3D10.1021%2Facsmedchemlett.5b00485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">3127</span>– <span class="NLM_lpage">3132</span>, <span class="refDoi"> DOI: 10.1073/pnas.1700234114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1073%2Fpnas.1700234114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=28270606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=3127-3132&author=J.+M.+Masonauthor=X.+Weiauthor=G.+C.+Fletcherauthor=R.+Kiarashauthor=R.+Brokxauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=M.+R.+Brayauthor=T.+W.+Mak&title=Functional+characterization+of+CFI-402257%2C+a+potent+and+selective+Mps1%2FTTK+kinase+inhibitor%2C+for+the+treatment+of+cancer&doi=10.1073%2Fpnas.1700234114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer</span></div><div class="casAuthors">Mason, Jacqueline M.; Wei, Xin; Fletcher, Graham C.; Kiarash, Reza; Brokx, Richard; Hodgson, Richard; Beletskaya, Irina; Bray, Mark R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3127-3132</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Loss of cell-cycle control is a hallmark of human cancer.  Cell-cycle checkpoints are essential for maintaining genome integrity and balanced growth and division.  They are specifically deregulated in cancer cells and contain regulators that represent potential therapeutic targets.  Monopolar spindle 1 (Mps1; also known as TTK protein kinase) is a core component of the spindle assembly checkpoint (SAC), a genome-surveillance mechanism that is important for cell survival, and has emerged as a candidate target for anticancer therapy.  Here, the authors report the cellular and antitumor effects of CFI-402257, a potent (Mps1 Ki = 0.09±0.02 nM; cellular Mps1 EC50 = 6.5±0.5 nM), highly selective, and orally active small-mol. inhibitor of Mps1 that was identified through a drug-discovery program.  Human cancer cells treated with CFI-402257 exhibit effects consistent with Mps1 kinase inhibition, specifically SAC inactivation, leading to chromosome missegregation, aneuploidy, and ultimately cell death.  Oral administration of CFI-402257 in monotherapy or in combination with an anti-programmed cell death 1 (PD-1) antibody in mouse models of human cancer results in inhibition of tumor growth at doses that are well-tolerated.  The authors' findings provide a rationale for the clin. evaluation of CFI-402257 in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQJ3eg_c-qLVg90H21EOLACvtfcHk0li0lkc5XDFyKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D&md5=bb9742c8d07314e7d3c322bef71ef0ff</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1700234114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1700234114%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DBrokx%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DFunctional%2520characterization%2520of%2520CFI-402257%252C%2520a%2520potent%2520and%2520selective%2520Mps1%252FTTK%2520kinase%2520inhibitor%252C%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D3127%26epage%3D3132%26doi%3D10.1073%2Fpnas.1700234114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurden, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, C. P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderhub, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven Brandon, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">vanMontfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span> <span> </span><span class="NLM_article-title">Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1166</span>– <span class="NLM_lpage">1176</span>, <span class="refDoi"> DOI: 10.1038/bjc.2017.75</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1038%2Fbjc.2017.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=28334731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=1166-1176&author=A.+Faisalauthor=G.+W.+Y.+Makauthor=M.+D.+Gurdenauthor=C.+P.+R.+Xavierauthor=S.+J.+Anderhubauthor=P.+Innocentiauthor=I.+M.+Westwoodauthor=S.+Naudauthor=A.+Hayesauthor=G.+Boxauthor=M.+R.+Valentiauthor=A.+K.+De+Haven+Brandonauthor=L.+O%E2%80%99Feeauthor=J.+Schmittauthor=H.+L.+Woodwardauthor=R.+Burkeauthor=R.+L.+M.+vanMontfortauthor=J.+Blaggauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Hoelderauthor=S.+Linardopoulos&title=Characterisation+of+CCT271850%2C+a+selective%2C+oral+and+potent+MPS1+inhibitor%2C+used+to+directly+measure+in+vivo+MPS1+inhibition+vs+therapeutic+efficacy&doi=10.1038%2Fbjc.2017.75"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy</span></div><div class="casAuthors">Faisal, Amir; Mak, Grace W. Y.; Gurden, Mark D.; Xavier, Cristina P. R.; Anderhub, Simon J.; Innocenti, Paolo; Westwood, Isaac M.; Naud, Sebastien; Hayes, Angela; Box, Gary; Valenti, Melanie R.; De Haven Brandon, Alexis K.; O'Fee, Lisa; Schmitt, Jessica; Woodward, Hannah L.; Burke, Rosemary; van Montfort, Rob L. M.; Blagg, Julian; Raynaud, Florence I.; Eccles, Suzanne A.; Hoelder, Swen; Linardopoulos, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1166-1176</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: The main role of the cell cycle is to enable error-free DNA replication, chromosome segregation and cytokinesis.  One of the best characterized checkpoint pathways is the spindle assembly checkpoint, which prevents anaphase onset until the appropriate attachment and tension across kinetochores is achieved.  MPS1 kinase activity is essential for the activation of the spindle assembly checkpoint and has been shown to be deregulated in human tumors with chromosomal instability and aneuploidy.  Therefore, MPS1 inhibition represents an attractive strategy to target cancers.  Methods: To evaluate CCT271850 cellular potency, two specific antibodies that recognize the activation sites of MPS1 were used and its antiproliferative activity was detd. in 91 human cancer cell lines.  DLD1 cells with induced GFP-MPS1 and HCT116 cells were used in in vivo studies to directly measure MPS1 inhibition and efficacy of CCT271850 treatment.  Results: CCT271850 selectively and potently inhibits MPS1 kinase activity in biochem. and cellular assays and in in vivo models.  Mechanistically, tumor cells treated with CCT271850 acquire aberrant nos. of chromosomes and the majority of cells divide their chromosomes without proper alignment because of abrogation of the mitotic checkpoint, leading to cell death.  We demonstrated a moderate level of efficacy of CCT271850 as a single agent in a human colorectal carcinoma xenograft model.  Conclusions: CCT271850 is a potent, selective and orally bioavailable MPS1 kinase inhibitor.  On the basis of in vivo pharmacodynamic vs efficacy relationships, we predict that more than 80% inhibition of MPS1 activity for at least 24 h is required to achieve tumor stasis or regression by CCT271850.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodu8v7zdjvabVg90H21EOLACvtfcHk0ljGzVJ-ZWS6jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKht74%253D&md5=656368a488e47677a8cb455de962371e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2017.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2017.75%26sid%3Dliteratum%253Aachs%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.%2BY.%26aulast%3DGurden%26aufirst%3DM.%2BD.%26aulast%3DXavier%26aufirst%3DC.%2BP.%2BR.%26aulast%3DAnderhub%26aufirst%3DS.%2BJ.%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%2BR.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%2BK.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DvanMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DLinardopoulos%26aufirst%3DS.%26atitle%3DCharacterisation%2520of%2520CCT271850%252C%2520a%2520selective%252C%2520oral%2520and%2520potent%2520MPS1%2520inhibitor%252C%2520used%2520to%2520directly%2520measure%2520in%2520vivo%2520MPS1%2520inhibition%2520vs%2520therapeutic%2520efficacy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2017%26volume%3D116%26spage%3D1166%26epage%3D1176%26doi%3D10.1038%2Fbjc.2017.75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solanki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matijssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Rapid discovery of pyrido[3,4-d]pyrimidine inhibitors of monopolar spindle kinase 1 (MPS1) using a structure-based hybridization approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3671</span>– <span class="NLM_lpage">3688</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01811</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01811" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2qsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3671-3688&author=P.+Innocentiauthor=H.+L.+Woodwardauthor=S.+Solankiauthor=S.+Naudauthor=I.+M.+Westwoodauthor=N.+Croninauthor=A.+Hayesauthor=J.+Robertsauthor=A.+T.+Henleyauthor=R.+Bakerauthor=A.+Faisalauthor=G.+W.+Makauthor=G.+Boxauthor=M.+Valentiauthor=A.+De+Haven+Brandonauthor=L.+O%E2%80%99Feeauthor=H.+Savilleauthor=J.+Schmittauthor=B.+Matijssenauthor=R.+Burkeauthor=R.+L.+van+Montfortauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Linardopoulosauthor=J.+Blaggauthor=S.+Hoelder&title=Rapid+discovery+of+pyrido%5B3%2C4-d%5Dpyrimidine+inhibitors+of+monopolar+spindle+kinase+1+%28MPS1%29+using+a+structure-based+hybridization+approach&doi=10.1021%2Facs.jmedchem.5b01811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach</span></div><div class="casAuthors">Innocenti, Paolo; Woodward, Hannah L.; Solanki, Savade; Naud, Sebastien; Westwood, Isaac M.; Cronin, Nora; Hayes, Angela; Roberts, Jennie; Henley, Alan T.; Baker, Ross; Faisal, Amir; Mak, Grace Wing-Yan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; O'Fee, Lisa; Saville, Harry; Schmitt, Jessica; Matijssen, Berry; Burke, Rosemary; van Montfort, Rob L. M.; Raynaud, Florence I.; Eccles, Suzanne A.; Linardopoulos, Spiros; Blagg, Julian; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3671-3688</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (MPS1) plays a central role in the transition of cells from metaphase to anaphase and is one of the main components of the spindle assembly checkpoint.  Chromosomally unstable cancer cells rely heavily on MPS1 to cope with the stress arising from abnormal nos. of chromosomes and centrosomes and are thus more sensitive to MPS1 inhibition than normal cells.  We report the discovery and optimization of a series of new pyrido[3,4-d]pyrimidine based inhibitors via a structure-based hybridization approach from our previously reported inhibitor CCT251455 and a modestly potent screening hit.  Compds. in this novel series display excellent potency and selectivity for MPS1, which translates into biomarker modulation in an in vivo human tumor xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42v6loNvM1bVg90H21EOLACvtfcHk0lgBWX4FSBNn2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2qsro%253D&md5=dd858ed11744e0b036061baf5e2c181a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01811%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DCronin%26aufirst%3DN.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSaville%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DRapid%2520discovery%2520of%2520pyrido%255B3%252C4-d%255Dpyrimidine%2520inhibitors%2520of%2520monopolar%2520spindle%2520kinase%25201%2520%2528MPS1%2529%2520using%2520a%2520structure-based%2520hybridization%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3671%26epage%3D3688%26doi%3D10.1021%2Facs.jmedchem.5b01811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagashira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1760</span>– <span class="NLM_lpage">1775</span>, <span class="refDoi"> DOI: 10.1021/jm501599u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501599u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1760-1775&author=K.-i.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=T.+Yamamotoauthor=H.+Hashizumeauthor=K.+Nozuauthor=H.+Yoshidaauthor=G.+Tadanoauthor=S.+Tagashiraauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=S.+Andoauthor=M.+Maedaauthor=M.+Higakiauthor=Y.+Babaauthor=Y.+Nakamura&title=Discovery+of+imidazo%5B1%2C2-b%5Dpyridazine+derivatives%3A+selective+and+orally+available+Mps1+%28TTK%29+kinase+inhibitors+exhibiting+remarkable+antiproliferative+activity&doi=10.1021%2Fjm501599u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Imidazo[1,2-b]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity</span></div><div class="casAuthors">Kusakabe, Ken-ichi; Ide, Nobuyuki; Daigo, Yataro; Itoh, Takeshi; Yamamoto, Takahiko; Hashizume, Hiroshi; Nozu, Kohei; Yoshida, Hiroshi; Tadano, Genta; Tagashira, Sachie; Higashino, Kenichi; Okano, Yousuke; Sato, Yuji; Inoue, Makiko; Iguchi, Motofumi; Kanazawa, Takayuki; Ishioka, Yukichi; Dohi, Keiji; Kido, Yasuto; Sakamoto, Shingo; Ando, Shigeru; Maeda, Masahiro; Higaki, Masayo; Baba, Yoshiyasu; Nakamura, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1760-1775</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) is an attractive oncol. target due to its high expression level in cancer cells as well as the correlation of its expression levels with histol. grades of cancers.  An imidazo[1,2-a]pyrazine 10a was identified during an HTS campaign.  Although 10a exhibited good biochem. activity, its moderate cellular as well as antiproliferative activities needed to be improved.  The cocrystal structure of an analog of 10a guided our lead optimization to introduce substituents at the 6-position of the scaffold, giving the 6-aryl substituted 21b which had improved cellular activity but no oral bioavailability in rat.  Property-based optimization at the 6-position and a scaffold change led to the discovery of the imidazo[1,2-b]pyridazine-based 27f, an extremely potent (cellular Mps1 IC50 = 0.70 nM, A549 IC50 = 6.0 nM), selective Mps1 inhibitor over 192 kinases, which could be orally administered and was active in vivo.  This 27f demonstrated remarkable antiproliferative activity in the nanomolar range against various tissue cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8D9nRl5vWabVg90H21EOLACvtfcHk0lgBWX4FSBNn2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D&md5=bee62a50247a363dc3e35fcdeac6a64f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm501599u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501599u%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DNozu%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C2-b%255Dpyridazine%2520derivatives%253A%2520selective%2520and%2520orally%2520available%2520Mps1%2520%2528TTK%2529%2520kinase%2520inhibitors%2520exhibiting%2520remarkable%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1760%26epage%3D1775%26doi%3D10.1021%2Fjm501599u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uitdehaag, J. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Man, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen-Seegers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinsen, M. B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libouban, M. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterrenburg, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, J. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Vetter, J. R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Roos, J. A. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buijsman, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, G. J. R.</span></span> <span> </span><span class="NLM_article-title">Target residence time-guided optimization on TTK kinase results in inhibitors with potent anti-proliferative activity</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>429</i></span>,  <span class="NLM_fpage">2211</span>– <span class="NLM_lpage">2230</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2017.05.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1016%2Fj.jmb.2017.05.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=28539250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Wiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2017&pages=2211-2230&author=J.+C.+M.+Uitdehaagauthor=J.+de+Manauthor=N.+Willemsen-Seegersauthor=M.+B.+W.+Prinsenauthor=M.+A.+A.+Liboubanauthor=J.+G.+Sterrenburgauthor=J.+J.+P.+de+Witauthor=J.+R.+F.+de%0AVetterauthor=J.+A.+D.+M.+de+Roosauthor=R.+C.+Buijsmanauthor=G.+J.+R.+Zaman&title=Target+residence+time-guided+optimization+on+TTK+kinase+results+in+inhibitors+with+potent+anti-proliferative+activity&doi=10.1016%2Fj.jmb.2017.05.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity</span></div><div class="casAuthors">Uitdehaag, Joost C. M.; de Man, Jos; Willemsen-Seegers, Nicole; Prinsen, Martine B. W.; Libouban, Marion A. A.; Sterrenburg, Jan Gerard; de Wit, Joeri J. P.; de Vetter, Judith R. F.; de Roos, Jeroen A. D. M.; Buijsman, Rogier C.; Zaman, Guido J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">429</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2211-2230</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The protein kinase threonine tyrosine kinase (TTK; also known as Mps1) is a crit. component of the spindle assembly checkpoint and a promising drug target for the treatment of aggressive cancers, such as triple neg. breast cancer.  While the first TTK inhibitors have entered clin. trials, little is known about how the inhibition of TTK with small-mol. compds. affects cellular activity.  The authors studied the selective TTK inhibitor NTRC 0066-0, which was developed in the authors' own lab., together with 11 TTK inhibitors developed by other companies, including Mps-BAY2b, BAY 1161909, BAY 1217389 (Bayer), TC-Mps1-12 (Shionogi), and MPI-0479605 (Myrexis).  Parallel testing shows that the cellular activity of these TTK inhibitors correlates with their binding affinity to TTK and, more strongly, with target residence time.  TTK inhibitors are therefore an example where target residence time dets. activity in in vitro cellular assays.  X-ray structures and thermal stability expts. reveal that the most potent compds. induce a shift of the glycine-rich loop as a result of binding to the catalytic lysine at position 553.  This "lysine trap" disrupts the catalytic machinery.  Based on these insights, the authors developed TTK inhibitors, based on a (5,6-dihydro)pyrimido[4,5-e]indolizine scaffold, with longer target residence times, which further exploit an allosteric pocket surrounding Lys 553.  Their binding mode is new for kinase inhibitors and can be classified as hybrid Type I/Type III.  These inhibitors have very potent anti-proliferative activity that rivals classic cytotoxic therapy.  The authors' findings will open up new avenues for more applications for TTK inhibitors in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT_6mZVMoVTrVg90H21EOLACvtfcHk0ljmuQHDOYZPmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Wiuro%253D&md5=c02b149e673dec7b0212b37a4c7b0831</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2017.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2017.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DUitdehaag%26aufirst%3DJ.%2BC.%2BM.%26aulast%3Dde%2BMan%26aufirst%3DJ.%26aulast%3DWillemsen-Seegers%26aufirst%3DN.%26aulast%3DPrinsen%26aufirst%3DM.%2BB.%2BW.%26aulast%3DLibouban%26aufirst%3DM.%2BA.%2BA.%26aulast%3DSterrenburg%26aufirst%3DJ.%2BG.%26aulast%3Dde%2BWit%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3Dde%2BVetter%26aufirst%3DJ.%2BR.%2BF.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%2BA.%2BD.%2BM.%26aulast%3DBuijsman%26aufirst%3DR.%2BC.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%2BR.%26atitle%3DTarget%2520residence%2520time-guided%2520optimization%2520on%2520TTK%2520kinase%2520results%2520in%2520inhibitors%2520with%2520potent%2520anti-proliferative%2520activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2017%26volume%3D429%26spage%3D2211%26epage%3D2230%26doi%3D10.1016%2Fj.jmb.2017.05.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jemaà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senovilla, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brands, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prechtl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegelbauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrieu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castedo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Characterization of novel MPS1 inhibitors with preclinical anticancer activity</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1532</span>– <span class="NLM_lpage">1545</span>, <span class="refDoi"> DOI: 10.1038/cdd.2013.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1038%2Fcdd.2013.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=23933817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2gurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1532-1545&author=M.+Jema%C3%A0author=L.+Galluzziauthor=O.+Keppauthor=L.+Senovillaauthor=M.+Brandsauthor=U.+Boemerauthor=M.+Koppitzauthor=P.+Lienauauthor=S.+Prechtlauthor=V.+Schulzeauthor=G.+Siemeisterauthor=A.+M.+Wengnerauthor=D.+Mumbergauthor=K.+Ziegelbauerauthor=A.+Abrieuauthor=M.+Castedoauthor=I.+Vitaleauthor=G.+Kroemer&title=Characterization+of+novel+MPS1+inhibitors+with+preclinical+anticancer+activity&doi=10.1038%2Fcdd.2013.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of novel MPS1 inhibitors with preclinical anticancer activity</span></div><div class="casAuthors">Jemaa, M.; Galluzzi, L.; Kepp, O.; Senovilla, L.; Brands, M.; Boemer, U.; Koppitz, M.; Lienau, P.; Prechtl, S.; Schulze, V.; Siemeister, G.; Wengner, A. M.; Mumberg, D.; Ziegelbauer, K.; Abrieu, A.; Castedo, M.; Vitale, I.; Kroemer, G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1532-1545</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (MPS1), a mitotic kinase that is overexpressed in several human cancers, contributes to the alignment of chromosomes to the metaphase plate as well as to the execution of the spindle assembly checkpoint (SAC).  Here, we report the identification and functional characterization of three novel inhibitors of MPS1 of two independent structural classes, N-(4-{2-[(2-cyanophenyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}phenyl)-2-phenylacetamide (Mps-BAY1) (a triazolopyridine), N-cyclopropyl-4-{8-[(2-methylpropyl)amino]-6-(quinolin-5-yl)imidazo[1,2-a]pyrazin-3-yl}benzamide (Mps-BAY2a) and N-cyclopropyl-4-{8-(isobutylamino)imidazo[1,2-a]pyrazin-3-yl}benzamide (Mps-BAY2b) (two imidazopyrazines).  By selectively inactivating MPS1, these small inhibitors can arrest the proliferation of cancer cells, causing their polyploidization and/or their demise.  Cancer cells treated with Mps-BAY1 or Mps-BAY2a manifested multiple signs of mitotic perturbation including inefficient chromosomal congression during metaphase, unscheduled SAC inactivation and severe anaphase defects.  Videomicroscopic cell fate profiling of histone 2B-green fluorescent protein-expressing cells revealed the capacity of MPS1 inhibitors to subvert the correct timing of mitosis as they induce a premature anaphase entry in the context of misaligned metaphase plates.  Hence, in the presence of MPS1 inhibitors, cells either divided in a bipolar (but often asym.) manner or entered one or more rounds of abortive mitoses, generating gross aneuploidy and polyploidy, resp.  In both cases, cells ultimately succumbed to the mitotic catastrophe-induced activation of the mitochondrial pathway of apoptosis.  Of note, low doses of MPS1 inhibitors and paclitaxel (a microtubular poison) synergized at increasing the frequency of chromosome misalignments and missegregations in the context of SAC inactivation.  This resulted in massive polyploidization followed by the activation of mitotic catastrophe.  A synergistic interaction between paclitaxel and MPS1 inhibitors could also be demonstrated in vivo, as the combination of these agents efficiently reduced the growth of tumor xenografts and exerted superior antineoplastic effects compared with either compd. employed alone.  Altogether, these results suggest that MPS1 inhibitors may exert robust anticancer activity, either as standalone therapeutic interventions or combined with microtubule-targeting chems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHoriIGxHO_rVg90H21EOLACvtfcHk0ljmuQHDOYZPmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2gurjI&md5=867fb902b15b6df0f7049b069bd47a4c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2013.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2013.105%26sid%3Dliteratum%253Aachs%26aulast%3DJema%25C3%25A0%26aufirst%3DM.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DSenovilla%26aufirst%3DL.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DKoppitz%26aufirst%3DM.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DSchulze%26aufirst%3DV.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26aulast%3DAbrieu%26aufirst%3DA.%26aulast%3DCastedo%26aufirst%3DM.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DCharacterization%2520of%2520novel%2520MPS1%2520inhibitors%2520with%2520preclinical%2520anticancer%2520activity%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2013%26volume%3D20%26spage%3D1532%26epage%3D1545%26doi%3D10.1038%2Fcdd.2013.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosemund, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prechtl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raschke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisk, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Ahsen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreft, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brands, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegelbauer, K.</span></span> <span> </span><span class="NLM_article-title">Novel MPS1 kinase inhibitors with potent Antitumor Activity</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-15-0500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1158%2F1535-7163.mct-15-0500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=26832791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVSqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=583-592&author=A.+M.+Wengnerauthor=G.+Siemeisterauthor=M.+Koppitzauthor=V.+Schulzeauthor=D.+Kosemundauthor=U.+Klarauthor=D.+Stoeckigtauthor=R.+Neuhausauthor=P.+Lienauauthor=B.+Baderauthor=S.+Prechtlauthor=M.+Raschkeauthor=A.-L.+Friskauthor=O.+von+Ahsenauthor=M.+Michelsauthor=B.+Kreftauthor=F.+von+Nussbaumauthor=M.+Brandsauthor=D.+Mumbergauthor=K.+Ziegelbauer&title=Novel+MPS1+kinase+inhibitors+with+potent+Antitumor+Activity&doi=10.1158%2F1535-7163.mct-15-0500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity</span></div><div class="casAuthors">Wengner, Antje M.; Siemeister, Gerhard; Koppitz, Marcus; Schulze, Volker; Kosemund, Dirk; Klar, Ulrich; Stoeckigt, Detlef; Neuhaus, Roland; Lienau, Philip; Bader, Benjamin; Prechtl, Stefan; Raschke, Marian; Frisk, Anna-Lena; von Ahsen, Oliver; Michels, Martin; Kreft, Bertolt; von Nussbaum, Franz; Brands, Michael; Mumberg, Dominik; Ziegelbauer, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">583-592</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) has been shown to function as the key kinase that activates the spindle assembly checkpoint (SAC) to secure proper distribution of chromosomes to daughter cells.  Here, we report the structure and functional characterization of two novel selective Mps1 inhibitors, BAY 1161909 and BAY 1217389, derived from structurally distinct chem. classes.  BAY 1161909 and BAY 1217389 inhibited Mps1 kinase activity with IC50 values below 10 nmol/L while showing an excellent selectivity profile.  In cellular mechanistic assays, both Mps1 inhibitors abrogated nocodazole-induced SAC activity and induced premature exit from mitosis ("mitotic breakthrough"), resulting in multinuclearity and tumor cell death.  Both compds. efficiently inhibited tumor cell proliferation in vitro (IC50 nmol/L range).  In vivo, BAY 1161909 and BAY 1217389 achieved moderate efficacy in monotherapy in tumor xenograft studies.  However, in line with its unique mode of action, when combined with paclitaxel, low doses of Mps1 inhibitor reduced paclitaxel-induced mitotic arrest by the weakening of SAC activity.  As a result, combination therapy strongly improved efficacy over paclitaxel or Mps1 inhibitor monotreatment at the resp. MTDs in a broad range of xenograft models, including those showing acquired or intrinsic paclitaxel resistance.  Both Mps1 inhibitors showed good tolerability without adding toxicity to paclitaxel monotherapy.  These preclin. findings validate the innovative concept of SAC abrogation for cancer therapy and justify clin. proof-of-concept studies evaluating the Mps1 inhibitors BAY 1161909 and BAY 1217389 in combination with antimitotic cancer drugs to enhance their efficacy and potentially overcome resistance.  Mol Cancer Ther; 15(4); 583-92. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGZQmIvWHFcLVg90H21EOLACvtfcHk0ljD0M5cRZvdGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVSqt7g%253D&md5=f2b5cf0daf178088479be4be2aefa6b7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-15-0500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-15-0500%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DKoppitz%26aufirst%3DM.%26aulast%3DSchulze%26aufirst%3DV.%26aulast%3DKosemund%26aufirst%3DD.%26aulast%3DKlar%26aufirst%3DU.%26aulast%3DStoeckigt%26aufirst%3DD.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DBader%26aufirst%3DB.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DRaschke%26aufirst%3DM.%26aulast%3DFrisk%26aufirst%3DA.-L.%26aulast%3Dvon%2BAhsen%26aufirst%3DO.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3DKreft%26aufirst%3DB.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26atitle%3DNovel%2520MPS1%2520kinase%2520inhibitors%2520with%2520potent%2520Antitumor%2520Activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D583%26epage%3D592%26doi%3D10.1158%2F1535-7163.mct-15-0500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K.-M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven
Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broccatelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8226</span>– <span class="NLM_lpage">8240</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00690</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8226-8240&author=H.+L.+Woodwardauthor=P.+Innocentiauthor=K.-M.+J.+Cheungauthor=A.+Hayesauthor=J.+Robertsauthor=A.+T.+Henleyauthor=A.+Faisalauthor=G.+W.-Y.+Makauthor=G.+Boxauthor=I.+M.+Westwoodauthor=N.+Croninauthor=M.+Carterauthor=M.+Valentiauthor=A.+De+Haven%0ABrandonauthor=L.+O%E2%80%99Feeauthor=H.+Savilleauthor=J.+Schmittauthor=R.+Burkeauthor=F.+Broccatelliauthor=R.+L.+M.+van+Montfortauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Linardopoulosauthor=J.+Blaggauthor=S.+Hoelder&title=Introduction+of+a+Methyl+Group+Curbs+Metabolism+of+Pyrido%5B3%2C4-d%5Dpyrimidine+Monopolar+Spindle+1+%28MPS1%29+Inhibitors+and+Enables+the+Discovery+of+the+Phase+1+Clinical+Candidate+N2-%282-Ethoxy-4-%284-methyl-4H-1%2C2%2C4-triazol-3-yl%29phenyl%29-6-methyl-N8-neopentylpyrido%5B3%2C4-d%5Dpyrimidine-2%2C8-diamine+%28BOS172722%29&doi=10.1021%2Facs.jmedchem.8b00690"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00690%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.-Y.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DCronin%26aufirst%3DN.%26aulast%3DCarter%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSaville%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DBroccatelli%26aufirst%3DF.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DIntroduction%2520of%2520a%2520Methyl%2520Group%2520Curbs%2520Metabolism%2520of%2520Pyrido%255B3%252C4-d%255Dpyrimidine%2520Monopolar%2520Spindle%25201%2520%2528MPS1%2529%2520Inhibitors%2520and%2520Enables%2520the%2520Discovery%2520of%2520the%2520Phase%25201%2520Clinical%2520Candidate%2520N2-%25282-Ethoxy-4-%25284-methyl-4H-1%252C2%252C4-triazol-3-yl%2529phenyl%2529-6-methyl-N8-neopentylpyrido%255B3%252C4-d%255Dpyrimidine-2%252C8-diamine%2520%2528BOS172722%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8226%26epage%3D8240%26doi%3D10.1021%2Facs.jmedchem.8b00690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">Compound <b>20</b> binds comparably to related 2,5-trisubstituted-7<i>H</i>-pyrrolo-[2,3-<i>d</i>]pyrimidine analogs in the TTK ATP binding pocket (see PDB Code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B4W">6B4W</a>). Similar observed G-loop induced fit and binding site interactions are described in ref <a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">The Schrödinger Small-Molecule Drug Discovery Suite 2017-1, S., LLC, New York, NY, 2017 was used for all crystal structure and small molecule–protein visualization and analysis. Schrödinger Release 2017-1: Maestro, Schrödinger, LLC, New York, NY, 2017. Schrödinger Release 2017-1: Schrödinger Suite 2017-1 Protein Preparation Wizard; Epik, Schrödinger, LLC, New York, NY, 2016; Impact, Schrödinger, LLC, New York, NY, 2016; Prime, Schrödinger, LLC, New York, NY, 2017. Schrödinger Release 2017-1: SiteMap, Schrödinger, LLC, New York, NY, 2017. Halgren, T., “Identifying and characterizing binding sites and assessing druggability,” J. Chem. Inf. Model., 2009, 49, 377–389. Halgren, T., “New method for fast and accurate binding-site identification and analysis,” Chem. Biol. Drug Des., 2007, 69, 146–148.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">In the crystal structure, a molecule of pentaethylene glycol binds adjacent to the ligand and interacts directly with catalytic residue Lys553. The pentaenthylene glycol wraps around residue Lys553 and may influence the conformation of proximal residues. Also, the activation loop is not depicted in the structure, as it was not resolved. The ligand may also form additional interactions with the activation loop residues which are not present in the crystal structure.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">The residue Cys604 is small and fairly unique residue that creates a larger pocket in the hinge region of TTK relative to other kinases. For details refer to <i>J. Med. Chem.</i><b>2017</b>, <i>60</i>, 8989–9002, and references therein.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span> <i>SelectScreen Kinase Profiling Services</i>; <span class="NLM_publisher-name">Thermo Fisher Scientific</span>: <span class="NLM_publisher-loc">WI, USA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+SelectScreen+Kinase+Profiling+Services%3B+Thermo+Fisher+Scientific%3A+WI%2C+USA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSelectScreen%2520Kinase%2520Profiling%2520Services%26pub%3DThermo%2520Fisher%2520Scientific" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flagella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baptista, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodbeck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiske, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honigberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jubb, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katavolos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin-Koh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Mahony, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roose-Girma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urkowitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warming, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaylaoglu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span> <span> </span><span class="NLM_article-title">Effect of selective LRRK2 kinase inhibition on nonhuman primate lung</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">273ra15</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aaa3634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1126%2Fscitranslmed.aaa3634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=25653221" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=273ra15&author=R.+N.+Fujiauthor=M.+Flagellaauthor=M.+Bacaauthor=M.+A.+Baptistaauthor=J.+Brodbeckauthor=B.+K.+Chanauthor=B.+K.+Fiskeauthor=L.+Honigbergauthor=A.+M.+Jubbauthor=P.+Katavolosauthor=D.+W.+Leeauthor=S.+Lewin-Kohauthor=T.+Linauthor=X.+Liuauthor=S.+Liuauthor=J.+P.+Lyssikatosauthor=J.+O%E2%80%99Mahonyauthor=M.+Reicheltauthor=M.+Roose-Girmaauthor=Z.+Shengauthor=T.+Shererauthor=A.+Smithauthor=M.+Solonauthor=Z.+K.+Sweeneyauthor=J.+Tarrantauthor=A.+Urkowitzauthor=S.+Warmingauthor=M.+Yaylaogluauthor=S.+Zhangauthor=H.+Zhuauthor=A.+A.+Estradaauthor=R.+J.+Watts&title=Effect+of+selective+LRRK2+kinase+inhibition+on+nonhuman+primate+lung&doi=10.1126%2Fscitranslmed.aaa3634"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa3634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa3634%26sid%3Dliteratum%253Aachs%26aulast%3DFuji%26aufirst%3DR.%2BN.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DBaca%26aufirst%3DM.%26aulast%3DBaptista%26aufirst%3DM.%2BA.%26aulast%3DBrodbeck%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26aulast%3DHonigberg%26aufirst%3DL.%26aulast%3DJubb%26aufirst%3DA.%2BM.%26aulast%3DKatavolos%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLewin-Koh%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DJ.%26aulast%3DReichelt%26aufirst%3DM.%26aulast%3DRoose-Girma%26aufirst%3DM.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DSherer%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DSolon%26aufirst%3DM.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DUrkowitz%26aufirst%3DA.%26aulast%3DWarming%26aufirst%3DS.%26aulast%3DYaylaoglu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DEffect%2520of%2520selective%2520LRRK2%2520kinase%2520inhibition%2520on%2520nonhuman%2520primate%2520lung%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D273ra15%26doi%3D10.1126%2Fscitranslmed.aaa3634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Two decades under the influence of the rule of five and the changing properties of approved oral drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1701</span>– <span class="NLM_lpage">1704</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00686</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00686" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=1701-1704&author=M.+D.+Shultz&title=Two+decades+under+the+influence+of+the+rule+of+five+and+the+changing+properties+of+approved+oral+drugs&doi=10.1021%2Facs.jmedchem.8b00686"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00686%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DTwo%2520decades%2520under%2520the%2520influence%2520of%2520the%2520rule%2520of%2520five%2520and%2520the%2520changing%2520properties%2520of%2520approved%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D62%26spage%3D1701%26epage%3D1704%26doi%3D10.1021%2Facs.jmedchem.8b00686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minor, W.</span></span> <span> </span><span class="NLM_article-title">[20] Processing of X-ray diffraction data collected in oscillation mode</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1016/s0076-6879(97)76066-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=%5B20%5D+Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode&doi=10.1016%2Fs0076-6879%2897%2976066-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0ljWpsfYQAq8iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3D%255B20%255D%2520Processing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326%26doi%3D10.1016%2Fs0076-6879%2897%2976066-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/s0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2Fs0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0ljWpsfYQAq8iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2Fs0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/s0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2Fs0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0livp8_Y7gEzww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2Fs0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/s0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2Fs0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0livp8_Y7gEzww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2Fs0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':[],'ref20':[],'ref21':[],'ref22':[],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Younho Lee, Hyunkyung Kim, Haelee Kim, Ha Yeon Cho, Jun-Goo Jee, Kyung-Ah Seo, Jung Beom Son, Eunhwa Ko, Hwan Geun Choi, Nam Doo Kim, <span class="NLM_string-name hlFld-ContribAuthor">Ikyon Kim</span>. </span><span class="cited-content_cbyCitation_article-title">X-ray Crystal Structure-Guided Design and Optimization of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile Scaffold as a Potent and Orally Active Monopolar Spindle 1 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6985-6995. <a href="https://doi.org/10.1021/acs.jmedchem.1c00542" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00542%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DX-ray%252BCrystal%252BStructure-Guided%252BDesign%252Band%252BOptimization%252Bof%252B7H-Pyrrolo%25255B2%25252C3-d%25255Dpyrimidine-5-carbonitrile%252BScaffold%252Bas%252Ba%252BPotent%252Band%252BOrally%252BActive%252BMonopolar%252BSpindle%252B1%252BInhibitor%26aulast%3DLee%26aufirst%3DYounho%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D25032021%26date%3D04052021%26volume%3D64%26issue%3D10%26spage%3D6985%26epage%3D6995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minhao  Huang</span>, <span class="hlFld-ContribAuthor ">Yongjun  Huang</span>, <span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Lei  Yu</span>, <span class="hlFld-ContribAuthor ">Yu  Chang</span>, <span class="hlFld-ContribAuthor ">Xiaolu  Wang</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Yanhui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Zhimin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113023. <a href="https://doi.org/10.1016/j.ejmech.2020.113023" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrido%25255B2%25252C%252B3-d%25255Dpyrimidin-7%2525288H%252529-ones%252Bas%252Bnew%252Bselective%252Borally%252Bbioavailable%252BThreonine%252BTyrosine%252BKinase%252B%252528TTK%252529%252Binhibitors%26aulast%3DHuang%26aufirst%3DMinhao%26date%3D2021%26volume%3D211%26spage%3D113023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhengtong  Mao</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Gaoyang  Zhu</span>, <span class="hlFld-ContribAuthor ">Jing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xingxian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-metal-free highly regioselective C–H acetoxylation of pyrrolo[2,3-
              d
              ]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (18)
                                     , 2696-2702. <a href="https://doi.org/10.1039/D0QO00702A" title="DOI URL">https://doi.org/10.1039/D0QO00702A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00702A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00702A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DTransition-metal-free%252Bhighly%252Bregioselective%252BC%2525E2%252580%252593H%252Bacetoxylation%252Bof%252Bpyrrolo%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%252Bderivatives%26aulast%3DMao%26aufirst%3DZhengtong%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D18%26spage%3D2696%26epage%3D2702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Yi</span>, <span class="hlFld-ContribAuthor ">Tianye  Li</span>, <span class="hlFld-ContribAuthor ">Shuang  Qin</span>, <span class="hlFld-ContribAuthor ">Shengnan  Yu</span>, <span class="hlFld-ContribAuthor ">Qian  Chu</span>, <span class="hlFld-ContribAuthor ">Anping  Li</span>, <span class="hlFld-ContribAuthor ">Kongming  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2020,</strong> <em>2020 </em>, 1-15. <a href="https://doi.org/10.1155/2020/4169691" title="DOI URL">https://doi.org/10.1155/2020/4169691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/4169691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F4169691%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DIdentifying%252BTumorigenesis%252Band%252BPrognosis-Related%252BGenes%252Bof%252BLung%252BAdenocarcinoma%25253A%252BBased%252Bon%252BWeighted%252BGene%252BCoexpression%252BNetwork%252BAnalysis%26aulast%3DYi%26aufirst%3DMing%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of iv starting point CC-671.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>4–20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SEM-Cl, NaH, DMF, 0–22 °C; (b) R<sub>1</sub>-alcohol, 1,4-dioxane, NaO<i>t</i>Bu, 70–90 °C; (c) R<sub>2</sub>-amine, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C; (d) TFA, DCM; (e) NH<sub>4</sub>OH, MeOH; and (f) TBAF, THF, 50 °C.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CAL-51 proliferation compared to CAL-51 <i>p</i>-TTK.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. TTK substrate phosphorylation inhibition post treatment with compound <b>20</b> as measured by western blot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Co-crystal structure of <b>20</b> bound in the ATP pocket of TTK. Residues within 4.0 Å of the ligand are shown (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N6O">6N6O</a>). The activation loop (residues 670–684) is disordered and not resolved in the crystal structure (some residues eliminated for clarity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. CAL-51 tumor xenograft studies with BID and QD once weekly dosing of compound <b>20</b>. On day 31, all treatment groups were significantly (*<i>p</i> < 0.001, one way ANOVA) different compared to the vehicle-treated group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/medium/jm-2018-01869r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Single dose study with compound <b>20</b> measuring PK, pHH3, and cleaved caspase in CAL-51 tumors (*<i>p</i> < 0.05, ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001 one way ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01869/20190502/images/large/jm-2018-01869r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01869&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cashion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deyanat-Yazdi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moghaddam, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahmanyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagarigan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBrun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leftheris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boylan, J. F.</span></span> <span> </span><span class="NLM_article-title">The discovery of a dual TTK protein kinase/CDC2-like kinase (CLK2) inhibitor for the treatment of triple negative breast cancer initiated from a phenotypic screen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8989</span>– <span class="NLM_lpage">9002</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01223</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01223" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1amu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8989-9002&author=J.+R.+Riggsauthor=M.+Nagyauthor=J.+Elsnerauthor=P.+Erdmanauthor=D.+Cashionauthor=D.+Robinsonauthor=R.+Harrisauthor=D.+Huangauthor=L.+Tehraniauthor=G.+Deyanat-Yazdiauthor=R.+K.+Narlaauthor=X.+Pengauthor=T.+Tranauthor=L.+Barnesauthor=T.+Millerauthor=J.+Katzauthor=Y.+Tangauthor=M.+Chenauthor=M.+F.+Moghaddamauthor=S.+Bahmanyarauthor=B.+Pagariganauthor=S.+Delkerauthor=L.+LeBrunauthor=P.+P.+Chamberlainauthor=A.+Calabreseauthor=S.+S.+Cananauthor=K.+Leftherisauthor=D.+Zhuauthor=J.+F.+Boylan&title=The+discovery+of+a+dual+TTK+protein+kinase%2FCDC2-like+kinase+%28CLK2%29+inhibitor+for+the+treatment+of+triple+negative+breast+cancer+initiated+from+a+phenotypic+screen&doi=10.1021%2Facs.jmedchem.7b01223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen</span></div><div class="casAuthors">Riggs, Jennifer R.; Nagy, Mark; Elsner, Jan; Erdman, Paul; Cashion, Dan; Robinson, Dale; Harris, Roy; Huang, Dehua; Tehrani, Lida; Deyanat-Yazdi, Gordafaried; Narla, Rama Krishna; Peng, Xiaohui; Tran, Tam; Barnes, Leo; Miller, Terra; Katz, Jason; Tang, Yang; Chen, Ming; Moghaddam, Mehran F.; Bahmanyar, Sogole; Pagarigan, Barbra; Delker, Silvia; LeBrun, Laurie; Chamberlain, Philip P.; Calabrese, Andrew; Canan, Stacie S.; Leftheris, Katerina; Zhu, Dan; Boylan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8989-9002</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Triple neg. breast cancer (TNBC) remains a serious unmet medical need with discouragingly high relapse rates.  The authors report here the synthesis and structure-activity relationship (SAR) of a novel series of 2,4,5-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines with potent activity against TNBC tumor cell lines.  These compds. were discovered from a TNBC phenotypic screen and possess a unique dual inhibition profile targeting TTK (mitotic exit) and CLK2 (mRNA splicing).  Design and optimization, driven with a TNBC tumor cell assay, identified potent and selective compds. with favorable in vitro and in vivo activity profiles and good iv PK properties.  This cell-based driven SAR produced compds. with strong single agent in vivo efficacy in multiple TNBC xenograft models without significant body wt. loss.  These data supported the nomination of CC-671 (compd. I) into IND-enabling studies as a single agent TNBC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZC5zKGXAFFLVg90H21EOLACvtfcHk0lgk7KpS10MmRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1amu77E&md5=0e55c6e9ad0e57dd189cccfd19b574bc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01223%26sid%3Dliteratum%253Aachs%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DNagy%26aufirst%3DM.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DErdman%26aufirst%3DP.%26aulast%3DCashion%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DDeyanat-Yazdi%26aufirst%3DG.%26aulast%3DNarla%26aufirst%3DR.%2BK.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DBarnes%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DMoghaddam%26aufirst%3DM.%2BF.%26aulast%3DBahmanyar%26aufirst%3DS.%26aulast%3DPagarigan%26aufirst%3DB.%26aulast%3DDelker%26aufirst%3DS.%26aulast%3DLeBrun%26aufirst%3DL.%26aulast%3DChamberlain%26aufirst%3DP.%2BP.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DCanan%26aufirst%3DS.%2BS.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520discovery%2520of%2520a%2520dual%2520TTK%2520protein%2520kinase%252FCDC2-like%2520kinase%2520%2528CLK2%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520triple%2520negative%2520breast%2520cancer%2520initiated%2520from%2520a%2520phenotypic%2520screen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8989%26epage%3D9002%26doi%3D10.1021%2Facs.jmedchem.7b01223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deyanat-Yazdi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikolon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymon, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boylan, J. F.</span></span> <span> </span><span class="NLM_article-title">Synthetic lethal strategy identifies a potent and selective TTK and CLK1/2 inhibitor for treatment of triple-negative breast cancer with a compromised G1-S checkpoint</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1727</span>– <span class="NLM_lpage">1738</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-17-1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1158%2F1535-7163.mct-17-1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=29866747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWrtrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1727-1738&author=D.+Zhuauthor=S.+Xuauthor=G.+Deyanat-Yazdiauthor=S.+X.+Pengauthor=L.+A.+Barnesauthor=R.+K.+Narlaauthor=T.+Tranauthor=D.+Mikolonauthor=Y.+Ningauthor=T.+Shiauthor=N.+Jiangauthor=H.+K.+Raymonauthor=J.+R.+Riggsauthor=J.+F.+Boylan&title=Synthetic+lethal+strategy+identifies+a+potent+and+selective+TTK+and+CLK1%2F2+inhibitor+for+treatment+of+triple-negative+breast+cancer+with+a+compromised+G1-S+checkpoint&doi=10.1158%2F1535-7163.mct-17-1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK1/2 Inhibitor for Treatment of Triple-Negative Breast Cancer with a Compromised G1-S Checkpoint</span></div><div class="casAuthors">Zhu, Dan; Xu, Shuichan; Deyanat-Yazdi, Gordafaried; Peng, Sophie X.; Barnes, Leo A.; Narla, Rama Krishna; Tran, Tam; Mikolon, David; Ning, Yuhong; Shi, Tao; Jiang, Ning; Raymon, Heather K.; Riggs, Jennifer R.; Boylan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1727-1738</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Historically, phenotypic-based drug discovery has yielded a high percentage of novel drugs while uncovering new tumor biol.  CC-671 was discovered using a phenotypic screen for compds. that preferentially induced apoptosis in triple-neg. breast cancer cell lines while sparing luminal breast cancer cell lines.  Detailed in vitro kinase profiling shows CC-671 potently and selectively inhibits two kinases-TTK and CLK2.  Cellular mechanism of action studies demonstrate that CC-671 potently inhibits the phosphorylation of KNL1 and SRp75, direct TTK and CLK2 substrates, resp.  Furthermore, CC-671 causes mitotic acceleration and modification of pre-mRNA splicing leading to apoptosis, consistent with cellular TTK and CLK inhibition.  Correlative anal. of genomic and potency data against a large panel of breast cancer cell lines identifies breast cancer cells with a dysfunctional G1-S checkpoint as more sensitive to CC-671, suggesting synthetic lethality between G1-S checkpoint and TTK/CLK2 inhibition.  Furthermore, significant in vivo CC-671 efficacy was demonstrated in two cell line-derived and one patient tumor-derived xenograft models of triple-neg. breast cancer (TNBC) following weekly dosing.  These findings are the first to demonstrate the unique inhibitory combination activity of a dual TTK/CLK2 inhibitor that preferably kills TNBC cells and shows synthetic lethality with a compromised G1-S checkpoint in breast cancer cell lines.  On the basis of these data, CC-671 was moved forward for clin. development as a potent and selective TTK/CLK2 inhibitor in a subset of patients with TNBC.  Mol Cancer Ther; 17(8); 1727-38. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolp4FNUUf1V7Vg90H21EOLACvtfcHk0lhkql3oWmsJiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWrtrbF&md5=1def06e14a8e056582ea792b37b26f6a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-17-1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-17-1084%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DDeyanat-Yazdi%26aufirst%3DG.%26aulast%3DPeng%26aufirst%3DS.%2BX.%26aulast%3DBarnes%26aufirst%3DL.%2BA.%26aulast%3DNarla%26aufirst%3DR.%2BK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DMikolon%26aufirst%3DD.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DRaymon%26aufirst%3DH.%2BK.%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26atitle%3DSynthetic%2520lethal%2520strategy%2520identifies%2520a%2520potent%2520and%2520selective%2520TTK%2520and%2520CLK1%252F2%2520inhibitor%2520for%2520treatment%2520of%2520triple-negative%2520breast%2520cancer%2520with%2520a%2520compromised%2520G1-S%2520checkpoint%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D1727%26epage%3D1738%26doi%3D10.1158%2F1535-7163.mct-17-1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiruma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacristan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachis, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuijt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubbink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Castelmur, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kops, G. J. P. L.</span></span> <span> </span><span class="NLM_article-title">Competition between MPS1 and microtubules at kinetochores regulates spindle checkpoint signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">1264</span>– <span class="NLM_lpage">1267</span>, <span class="refDoi"> DOI: 10.1126/science.aaa4055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1126%2Fscience.aaa4055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=26068855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps1Oltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2015&pages=1264-1267&author=Y.+Hirumaauthor=C.+Sacristanauthor=S.+T.+Pachisauthor=A.+Adamopoulosauthor=T.+Kuijtauthor=M.+Ubbinkauthor=E.+von+Castelmurauthor=A.+Perrakisauthor=G.+J.+P.+L.+Kops&title=Competition+between+MPS1+and+microtubules+at+kinetochores+regulates+spindle+checkpoint+signaling&doi=10.1126%2Fscience.aaa4055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Competition between MPS1 and microtubules at kinetochores regulates spindle checkpoint signaling</span></div><div class="casAuthors">Hiruma, Yoshitaka; Sacristan, Carlos; Pachis, Spyridon T.; Adamopoulos, Athanassios; Kuijt, Timo; Ubbink, Marcellus; von Castelmur, Eleonore; Perrakis, Anastassis; Kops, Geert J. P. L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6240</span>),
    <span class="NLM_cas:pages">1264-1267</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cell division progresses to anaphase only after all chromosomes are connected to spindle microtubules through kinetochores and the spindle assembly checkpoint (SAC) is satisfied.  Here, the authors show that the N-terminal localization module of SAC protein kinase MPS1 (monopolar spindle 1) directly interacts with the HEC1 (highly expressed in cancer 1) calponin homol. domain in the NDC80 (nuclear division cycle 80) kinetochore complex in vitro, in a phosphorylation-dependent manner.  Microtubule polymers disrupted this interaction.  In cells, MPS1 binding to kinetochores or to ectopic NDC80 complexes was prevented by end-on microtubule attachment, independent of known kinetochore protein-removal mechanisms.  Competition for kinetochore binding between SAC proteins and microtubules provides a direct and perhaps evolutionarily conserved way to detect a properly organized spindle ready for cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof51pqHltOW7Vg90H21EOLACvtfcHk0liuNf18AELFQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps1Oltb8%253D&md5=378c8e3c2fea7c70c1caeaa69dfd3f8f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaa4055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaa4055%26sid%3Dliteratum%253Aachs%26aulast%3DHiruma%26aufirst%3DY.%26aulast%3DSacristan%26aufirst%3DC.%26aulast%3DPachis%26aufirst%3DS.%2BT.%26aulast%3DAdamopoulos%26aufirst%3DA.%26aulast%3DKuijt%26aufirst%3DT.%26aulast%3DUbbink%26aufirst%3DM.%26aulast%3Dvon%2BCastelmur%26aufirst%3DE.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26atitle%3DCompetition%2520between%2520MPS1%2520and%2520microtubules%2520at%2520kinetochores%2520regulates%2520spindle%2520checkpoint%2520signaling%26jtitle%3DScience%26date%3D2015%26volume%3D348%26spage%3D1264%26epage%3D1267%26doi%3D10.1126%2Fscience.aaa4055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kops, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, R. H.</span></span> <span> </span><span class="NLM_article-title">Targeting the mitotic checkpoint to kill tumor cells</span>. <i>Horm. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1007/s12672-010-0059-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1007%2Fs12672-010-0059-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=21475725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnot1Wkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=113-116&author=A.+Janssenauthor=G.+J.+Kopsauthor=R.+H.+Medema&title=Targeting+the+mitotic+checkpoint+to+kill+tumor+cells&doi=10.1007%2Fs12672-010-0059-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the mitotic checkpoint to kill tumor cells</span></div><div class="casAuthors">Janssen Aniek; Kops Geert J; Medema Rene H</div><div class="citationInfo"><span class="NLM_cas:title">Hormones & cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">One of the most common hallmarks of cancer cells is aneuploidy or an abnormal number of chromosomes.  This abnormal chromosome content is a consequence of chromosome missegregation during mitosis, a defect that is seen more frequently in tumor cell divisions as in normal cell divisions.  In fact, a large fraction of human tumors display a chromosome instable phenotype, meaning that they very frequently missegregate chromosomes.  This can cause variegated aneuploidy within the tumor tissue.  It has been argued that this hallmark of cancer could be exploited in anti-cancer therapies.  Here we test this hypothesis by inactivation of the mitotic checkpoint through RNAi-mediated depletion of an essential checkpoint component, Mps1.  The mitotic checkpoint delays segregation of chromosomes during mitosis until all chromosomes are properly attached to the mitotic spindle.  Its inactivation will therefore lead to increased segregation errors.  Indeed, we show that this can lead to increased cell death in tumor cells.  We demonstrate that increased cell death is associated with a dramatic increase in segregation errors.  This suggests that inhibition of the mitotic checkpoint might represent a useful anti-cancer strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTx5ZlxKChceNts4TFFB11gfW6udTcc2eYmZ18b8e7Zzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnot1Wkug%253D%253D&md5=7ea1be16c9e26670ce447b0caca260c3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs12672-010-0059-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12672-010-0059-x%26sid%3Dliteratum%253Aachs%26aulast%3DJanssen%26aufirst%3DA.%26aulast%3DKops%26aufirst%3DG.%2BJ.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26atitle%3DTargeting%2520the%2520mitotic%2520checkpoint%2520to%2520kill%2520tumor%2520cells%26jtitle%3DHorm.%2520Cancer%26date%3D2011%26volume%3D2%26spage%3D113%26epage%3D116%26doi%3D10.1007%2Fs12672-010-0059-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennecozzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgini, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappella, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depaolini, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchi, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avanzi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossi, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesenti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, J.</span></span> <span> </span><span class="NLM_article-title">Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">10255</span>– <span class="NLM_lpage">10264</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-10-2101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1158%2F0008-5472.can-10-2101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10255-10264&author=R.+Colomboauthor=M.+Caldarelliauthor=M.+Mennecozziauthor=M.+L.+Giorginiauthor=F.+Solaauthor=P.+Cappellaauthor=C.+Perreraauthor=S.+R.+Depaoliniauthor=L.+Rusconiauthor=U.+Cucchiauthor=N.+Avanziauthor=J.+A.+Bertrandauthor=R.+T.+Bossiauthor=E.+Pesentiauthor=A.+Galvaniauthor=A.+Isacchiauthor=F.+Colottaauthor=D.+Donatiauthor=J.+Moll&title=Targeting+the+mitotic+checkpoint+for+cancer+therapy+with+NMS-P715%2C+an+inhibitor+of+MPS1+kinase&doi=10.1158%2F0008-5472.can-10-2101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-10-2101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-10-2101%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DCaldarelli%26aufirst%3DM.%26aulast%3DMennecozzi%26aufirst%3DM.%26aulast%3DGiorgini%26aufirst%3DM.%2BL.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DCappella%26aufirst%3DP.%26aulast%3DPerrera%26aufirst%3DC.%26aulast%3DDepaolini%26aufirst%3DS.%2BR.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DCucchi%26aufirst%3DU.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DColotta%26aufirst%3DF.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DMoll%26aufirst%3DJ.%26atitle%3DTargeting%2520the%2520mitotic%2520checkpoint%2520for%2520cancer%2520therapy%2520with%2520NMS-P715%252C%2520an%2520inhibitor%2520of%2520MPS1%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D10255%26epage%3D10264%26doi%3D10.1158%2F0008-5472.can-10-2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maire, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldeyron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent-Salomon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty-Prouvost, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Koning, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigaill, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentien, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barillot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman-Roman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzalegui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierré, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, T.</span></span> <span> </span><span class="NLM_article-title">TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e63712</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0063712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1371%2Fjournal.pone.0063712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=23700430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslamtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=V.+Maireauthor=C.+Baldeyronauthor=M.+Richardsonauthor=B.+Tessonauthor=A.+Vincent-Salomonauthor=E.+Gravierauthor=B.+Marty-Prouvostauthor=L.+De+Koningauthor=G.+Rigaillauthor=A.+Dumontauthor=D.+Gentienauthor=E.+Barillotauthor=S.+Roman-Romanauthor=S.+Depilauthor=F.+Cruzaleguiauthor=A.+Pierr%C3%A9author=G.+C.+Tuckerauthor=T.+Dubois&title=TTK%2FhMPS1+is+an+attractive+therapeutic+target+for+triple-negative+breast+cancer&doi=10.1371%2Fjournal.pone.0063712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer</span></div><div class="casAuthors">Maire, Virginie; Baldeyron, Celine; Richardson, Marion; Tesson, Bruno; Vincent-Salomon, Anne; Gravier, Eleonore; Marty-Prouvost, Berengere; De Koning, Leanne; Rigaill, Guillem; Dumont, Aurelie; Gentien, David; Barillot, Emmanuel; Roman-Roman, Sergio; Depil, Stephane; Cruzalegui, Francisco; Pierre, Alain; Tucker, Gordon C.; Dubois, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e63712</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) represents a subgroup of breast cancers (BC) assocd. with the most aggressive clin. behavior.  No targeted therapy is currently available for the treatment of patients with TNBC.  In order to discover potential therapeutic targets, we searched for protein kinases that are overexpressed in human TNBC biopsies and whose silencing in TNBC cell lines causes cell death.  A cohort including human BC biopsies obtained at Institut Curie as well as normal tissues has been analyzed at a gene-expression level.  The data revealed that the human protein kinase monopolar spindle 1 (hMPS1), also known as TTK and involved in mitotic checkpoint, is specifically overexpressed in TNBC, compared to the other BC subgroups and healthy tissues.  We confirmed by immunohistochem. and reverse phase protein array that TNBC expressed higher levels of TTK protein compared to the other BC subgroups.  We then detd. the biol. effects of TTK depletion by RNA interference, through analyses of tumorigenic capacity and cell viability in different human TNBC cell lines.  We found that RNAi-mediated depletion of TTK in various TNBC cell lines severely compromised their viability and their ability to form colonies in an anchorage-independent manner.  Moreover, we obsd. that TTK silencing led to an increase in H2AX phosphorylation, activation of caspases 3/7, sub-G1 cell population accumulation and high annexin V staining, as well as to a decrease in G1 phase cell population and an increased aneuploidy.  Altogether, these data indicate that TTK depletion in TNBC cells induces apoptosis.  These results point out TTK as a protein kinase overexpressed in TNBC that may represent an attractive therapeutic target specifically for this poor prognosis assocd. subgroup of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCemS4PKt5pLVg90H21EOLACvtfcHk0lj4pHSshyD7eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslamtrs%253D&md5=21e30c2ca30b75839c07e13cdd19d897</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0063712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0063712%26sid%3Dliteratum%253Aachs%26aulast%3DMaire%26aufirst%3DV.%26aulast%3DBaldeyron%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DM.%26aulast%3DTesson%26aufirst%3DB.%26aulast%3DVincent-Salomon%26aufirst%3DA.%26aulast%3DGravier%26aufirst%3DE.%26aulast%3DMarty-Prouvost%26aufirst%3DB.%26aulast%3DDe%2BKoning%26aufirst%3DL.%26aulast%3DRigaill%26aufirst%3DG.%26aulast%3DDumont%26aufirst%3DA.%26aulast%3DGentien%26aufirst%3DD.%26aulast%3DBarillot%26aufirst%3DE.%26aulast%3DRoman-Roman%26aufirst%3DS.%26aulast%3DDepil%26aufirst%3DS.%26aulast%3DCruzalegui%26aufirst%3DF.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DTucker%26aufirst%3DG.%2BC.%26aulast%3DDubois%26aufirst%3DT.%26atitle%3DTTK%252FhMPS1%2520is%2520an%2520attractive%2520therapeutic%2520target%2520for%2520triple-negative%2520breast%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0063712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awrey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeira, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)benzamides as novel, highly potent and selective, orally bioavailable inhibitors of tyrosine threonine kinase, TTK</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3562</span>– <span class="NLM_lpage">3566</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1016%2Fj.bmcl.2016.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=27335255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKgtLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3562-3566&author=R.+Lauferauthor=S.-W.+Liauthor=Y.+Liuauthor=G.+Ngauthor=Y.+Langauthor=M.+Feherauthor=R.+Brokxauthor=I.+Beletskayaauthor=R.+Hodgsonauthor=G.+Maoauthor=O.+Plotnikovaauthor=D.+E.+Awreyauthor=J.+M.+Masonauthor=X.+Weiauthor=D.+C.-C.+Linauthor=Y.+Cheauthor=R.+Kiarashauthor=B.+Madeiraauthor=G.+C.+Fletcherauthor=T.+W.+Makauthor=M.+R.+Brayauthor=H.+W.+Pauls&title=Discovery+of+4-%284-aminopyrazolo%5B1%2C5-a%5D%5B1%2C3%2C5%5Dtriazin-8-yl%29benzamides+as+novel%2C+highly+potent+and+selective%2C+orally+bioavailable+inhibitors+of+tyrosine+threonine+kinase%2C+TTK&doi=10.1016%2Fj.bmcl.2016.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)benzamides as novel, highly potent and selective, orally bioavailable inhibitors of Tyrosine Threonine Kinase, TTK</span></div><div class="casAuthors">Laufer, Radoslaw; Li, Sze-Wan; Liu, Yong; Ng, Grace; Lang, Yunhui; Feher, Miklos; Brokx, Richard; Beletskaya, Irina; Hodgson, Richard; Mao, Guodong; Plotnikova, Olga; Awrey, Donald E.; Mason, Jacqueline M.; Wei, Xin; Lin, Dan Chi-Chia; Che, Yi; Kiarash, Reza; Madeira, Brian; Fletcher, Graham C.; Mak, Tak W.; Bray, Mark R.; Pauls, Henry W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3562-3566</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">TTK/Mps1 is a key kinase controlling progression of cell division via participation in the mitotic spindle assembly checkpoint and is overexpressed in a no. of human cancers.  Herein the authors report the discovery of 4-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)benzamides as a potent, novel class of TTK inhibitors.  The series was identified by bioisosteric replacement of the related imidazopyrazine and imidazopyridazine scaffolds.  Optimization led to the identification of compds. with excellent potency (Ki = 0.8 nM) and exceptional kinase selectivity.  The SAR indicates a strong dependence of activity on the presence of the N-cyclopropyl-2-methylbenzamide moiety delineating the geometry for 11/2 type kinase inhibitor.  Mol. modeling indicates the extensive and optimal contacts, mediated through H-bonds and hydrophobic interactions, are responsible for the selectivity and potency of the inhibitors.  The compds. demonstrate a strong anti-proliferative activity in a panel of human cancer cell lines (HCT116 GIC50 <15 nM) and good rodent pharmacokinetics (oral %F 97%).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTb2Z2xtkAWLVg90H21EOLACvtfcHk0lj66vjWVJhfYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKgtLnL&md5=d107d562ed4407d05bfbba57abcd6b98</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBrokx%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DMadeira%26aufirst%3DB.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%25204-%25284-aminopyrazolo%255B1%252C5-a%255D%255B1%252C3%252C5%255Dtriazin-8-yl%2529benzamides%2520as%2520novel%252C%2520highly%2520potent%2520and%2520selective%252C%2520orally%2520bioavailable%2520inhibitors%2520of%2520tyrosine%2520threonine%2520kinase%252C%2520TTK%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3562%26epage%3D3566%26doi%3D10.1016%2Fj.bmcl.2016.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awrey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris-Brandts, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadeem, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirgadze, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4968</span>– <span class="NLM_lpage">4997</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1016%2Fj.bmc.2014.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=25043312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyjt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4968-4997&author=R.+Lauferauthor=G.+Ngauthor=Y.+Liuauthor=N.+K.+B.+Patelauthor=L.+G.+Edwardsauthor=Y.+Langauthor=S.-W.+Liauthor=M.+Feherauthor=D.+E.+Awreyauthor=G.+Leungauthor=I.+Beletskayaauthor=O.+Plotnikovaauthor=J.+M.+Masonauthor=R.+Hodgsonauthor=X.+Weiauthor=G.+Maoauthor=X.+Luoauthor=P.+Huangauthor=E.+Greenauthor=R.+Kiarashauthor=D.+C.-C.+Linauthor=M.+Harris-Brandtsauthor=F.+Banauthor=V.+Nadeemauthor=T.+W.+Makauthor=G.+J.+Panauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=H.+W.+Pauls&title=Discovery+of+inhibitors+of+the+mitotic+kinase+TTK+based+on+N-%283-%283-sulfamoylphenyl%29-1H-indazol-5-yl%29-acetamides+and+carboxamides&doi=10.1016%2Fj.bmc.2014.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)acetamides and carboxamides</span></div><div class="casAuthors">Laufer, Radoslaw; Ng, Grace; Liu, Yong; Patel, Narendra Kumar B.; Edwards, Louise G.; Lang, Yunhui; Li, Sze-Wan; Feher, Miklos; Awrey, Don E.; Leung, Genie; Beletskaya, Irina; Plotnikova, Olga; Mason, Jacqueline M.; Hodgson, Richard; Wei, Xin; Mao, Guodong; Luo, Xunyi; Huang, Ping; Green, Erin; Kiarash, Reza; Lin, Dan Chi-Chia; Harris-Brandts, Marees; Ban, Fuqiang; Nadeem, Vincent; Mak, Tak W.; Pan, Guohua J.; Qiu, Wei; Chirgadze, Nickolay Y.; Pauls, Henry W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4968-4997</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">TTK kinase was identified by inhouse siRNA screen and pursued as a tractable, novel target for cancer treatment.  A screening campaign and systematic optimization, supported by computer modeling led to an indazole core with key sulfamoylphenyl and acetamido moieties at positions 3 and 5, resp., establishing a novel chem. class culminating in identification of I (CFI-400936).  This potent inhibitor of TTK (IC50 = 3.6 nM) demonstrated good activity in cell based assay and selectivity against a panel of human kinases.  A complex TTK x-ray crystal structure and results of a xenograft study with TTK inhibitors from this class are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYMVdifCP5IrVg90H21EOLACvtfcHk0lj66vjWVJhfYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyjt7fK&md5=71dac8de6f21ee67d1c18fd4e521a4f9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%2BB.%26aulast%3DEdwards%26aufirst%3DL.%2BG.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DHarris-Brandts%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DG.%2BJ.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%2520inhibitors%2520of%2520the%2520mitotic%2520kinase%2520TTK%2520based%2520on%2520N-%25283-%25283-sulfamoylphenyl%2529-1H-indazol-5-yl%2529-acetamides%2520and%2520carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4968%26epage%3D4997%26doi%3D10.1016%2Fj.bmc.2014.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awrey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirgadze, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeira, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">The discovery of orally bioavailable tyrosine threonine kinase (TTK) inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3366</span>– <span class="NLM_lpage">3392</span>, <span class="refDoi"> DOI: 10.1021/jm501740a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501740a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3366-3392&author=Y.+Liuauthor=Y.+Langauthor=N.+K.+Patelauthor=G.+Ngauthor=R.+Lauferauthor=S.-W.+Liauthor=L.+Edwardsauthor=B.+Forrestauthor=P.+B.+Sampsonauthor=M.+Feherauthor=F.+Banauthor=D.+E.+Awreyauthor=I.+Beletskayaauthor=G.+Maoauthor=R.+Hodgsonauthor=O.+Plotnikovaauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=J.+M.+Masonauthor=X.+Weiauthor=D.+C.-C.+Linauthor=Y.+Cheauthor=R.+Kiarashauthor=B.+Madeiraauthor=G.+C.+Fletcherauthor=T.+W.+Makauthor=M.+R.+Brayauthor=H.+W.+Pauls&title=The+discovery+of+orally+bioavailable+tyrosine+threonine+kinase+%28TTK%29+inhibitors%3A+3-%284-%28heterocyclyl%29phenyl%29-1H-indazole-5-carboxamides+as+anticancer+agents&doi=10.1021%2Fjm501740a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm501740a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501740a%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DForrest%26aufirst%3DB.%26aulast%3DSampson%26aufirst%3DP.%2BB.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DMadeira%26aufirst%3DB.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520orally%2520bioavailable%2520tyrosine%2520threonine%2520kinase%2520%2528TTK%2529%2520inhibitors%253A%25203-%25284-%2528heterocyclyl%2529phenyl%2529-1H-indazole-5-carboxamides%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3366%26epage%3D3392%26doi%3D10.1021%2Fjm501740a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awrey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirgadze, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyrazolo[1,5-a]pyrimidine TTK inhibitors: CFI-402257 is a potent, selective, bioavailable anticancer agent</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">675</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00485</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC28Xntl2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=671-675&author=Y.+Liuauthor=R.+Lauferauthor=N.+K.+Patelauthor=G.+Ngauthor=P.+B.+Sampsonauthor=S.-W.+Liauthor=Y.+Langauthor=M.+Feherauthor=R.+Brokxauthor=I.+Beletskayaauthor=R.+Hodgsonauthor=O.+Plotnikovaauthor=D.+E.+Awreyauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=J.+M.+Masonauthor=X.+Weiauthor=D.+C.-C.+Linauthor=Y.+Cheauthor=R.+Kiarashauthor=G.+C.+Fletcherauthor=T.+W.+Makauthor=M.+R.+Brayauthor=H.+W.+Pauls&title=Discovery+of+pyrazolo%5B1%2C5-a%5Dpyrimidine+TTK+inhibitors%3A+CFI-402257+is+a+potent%2C+selective%2C+bioavailable+anticancer+agent&doi=10.1021%2Facsmedchemlett.5b00485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyrazolo[1,5-a]pyrimidine TTK Inhibitors: CFI-402257 is a Potent, Selective, Bioavailable Anticancer Agent</span></div><div class="casAuthors">Liu, Yong; Laufer, Radoslaw; Patel, Narendra Kumar; Ng, Grace; Sampson, Peter B.; Li, Sze-Wan; Lang, Yunhui; Feher, Miklos; Brokx, Richard; Beletskaya, Irina; Hodgson, Richard; Plotnikova, Olga; Awrey, Donald E.; Qiu, Wei; Chirgadze, Nickolay Y.; Mason, Jacqueline M.; Wei, Xin; Lin, Dan Chi-Chia; Che, Yi; Kiarash, Reza; Fletcher, Graham C.; Mak, Tak W.; Bray, Mark R.; Pauls, Henry W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">671-675</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work describes a scaffold hopping exercise that begins with known imidazo[1,2-a]pyrazines, briefly explores pyrazolo[1,5-a][1,3,5]triazines, and ultimately yields pyrazolo[1,5-a]pyrimidines as a novel class of potent TTK inhibitors.  An X-ray structure of a representative compd. is consistent with 11/2 type inhibition and provides structural insight to aid subsequent optimization of in vitro activity and physicochem. and pharmacokinetic properties.  Incorporation of polar moieties in the hydrophobic and solvent accessible regions modulates physicochem. properties while maintaining potency.  Compds. with enhanced oral exposure were identified for xenograft studies.  The work culminates in the identification of a potent (TTK Ki = 0.1 nM), highly selective, orally bioavailable anticancer agent (CFI-402257) for IND enabling studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YPAge-MdqLVg90H21EOLACvtfcHk0lhbSHV7zp0byA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xntl2isLo%253D&md5=3eb4e1971e0c0a73e6eee657ac9d6fe0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00485%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DN.%2BK.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DSampson%26aufirst%3DP.%2BB.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBrokx%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520TTK%2520inhibitors%253A%2520CFI-402257%2520is%2520a%2520potent%252C%2520selective%252C%2520bioavailable%2520anticancer%2520agent%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D671%26epage%3D675%26doi%3D10.1021%2Facsmedchemlett.5b00485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">3127</span>– <span class="NLM_lpage">3132</span>, <span class="refDoi"> DOI: 10.1073/pnas.1700234114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1073%2Fpnas.1700234114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=28270606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=3127-3132&author=J.+M.+Masonauthor=X.+Weiauthor=G.+C.+Fletcherauthor=R.+Kiarashauthor=R.+Brokxauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=M.+R.+Brayauthor=T.+W.+Mak&title=Functional+characterization+of+CFI-402257%2C+a+potent+and+selective+Mps1%2FTTK+kinase+inhibitor%2C+for+the+treatment+of+cancer&doi=10.1073%2Fpnas.1700234114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer</span></div><div class="casAuthors">Mason, Jacqueline M.; Wei, Xin; Fletcher, Graham C.; Kiarash, Reza; Brokx, Richard; Hodgson, Richard; Beletskaya, Irina; Bray, Mark R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3127-3132</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Loss of cell-cycle control is a hallmark of human cancer.  Cell-cycle checkpoints are essential for maintaining genome integrity and balanced growth and division.  They are specifically deregulated in cancer cells and contain regulators that represent potential therapeutic targets.  Monopolar spindle 1 (Mps1; also known as TTK protein kinase) is a core component of the spindle assembly checkpoint (SAC), a genome-surveillance mechanism that is important for cell survival, and has emerged as a candidate target for anticancer therapy.  Here, the authors report the cellular and antitumor effects of CFI-402257, a potent (Mps1 Ki = 0.09±0.02 nM; cellular Mps1 EC50 = 6.5±0.5 nM), highly selective, and orally active small-mol. inhibitor of Mps1 that was identified through a drug-discovery program.  Human cancer cells treated with CFI-402257 exhibit effects consistent with Mps1 kinase inhibition, specifically SAC inactivation, leading to chromosome missegregation, aneuploidy, and ultimately cell death.  Oral administration of CFI-402257 in monotherapy or in combination with an anti-programmed cell death 1 (PD-1) antibody in mouse models of human cancer results in inhibition of tumor growth at doses that are well-tolerated.  The authors' findings provide a rationale for the clin. evaluation of CFI-402257 in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQJ3eg_c-qLVg90H21EOLACvtfcHk0ljpFP8ronErzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D&md5=bb9742c8d07314e7d3c322bef71ef0ff</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1700234114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1700234114%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DBrokx%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DFunctional%2520characterization%2520of%2520CFI-402257%252C%2520a%2520potent%2520and%2520selective%2520Mps1%252FTTK%2520kinase%2520inhibitor%252C%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D3127%26epage%3D3132%26doi%3D10.1073%2Fpnas.1700234114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurden, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, C. P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderhub, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven Brandon, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">vanMontfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span> <span> </span><span class="NLM_article-title">Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1166</span>– <span class="NLM_lpage">1176</span>, <span class="refDoi"> DOI: 10.1038/bjc.2017.75</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1038%2Fbjc.2017.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=28334731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=1166-1176&author=A.+Faisalauthor=G.+W.+Y.+Makauthor=M.+D.+Gurdenauthor=C.+P.+R.+Xavierauthor=S.+J.+Anderhubauthor=P.+Innocentiauthor=I.+M.+Westwoodauthor=S.+Naudauthor=A.+Hayesauthor=G.+Boxauthor=M.+R.+Valentiauthor=A.+K.+De+Haven+Brandonauthor=L.+O%E2%80%99Feeauthor=J.+Schmittauthor=H.+L.+Woodwardauthor=R.+Burkeauthor=R.+L.+M.+vanMontfortauthor=J.+Blaggauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Hoelderauthor=S.+Linardopoulos&title=Characterisation+of+CCT271850%2C+a+selective%2C+oral+and+potent+MPS1+inhibitor%2C+used+to+directly+measure+in+vivo+MPS1+inhibition+vs+therapeutic+efficacy&doi=10.1038%2Fbjc.2017.75"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy</span></div><div class="casAuthors">Faisal, Amir; Mak, Grace W. Y.; Gurden, Mark D.; Xavier, Cristina P. R.; Anderhub, Simon J.; Innocenti, Paolo; Westwood, Isaac M.; Naud, Sebastien; Hayes, Angela; Box, Gary; Valenti, Melanie R.; De Haven Brandon, Alexis K.; O'Fee, Lisa; Schmitt, Jessica; Woodward, Hannah L.; Burke, Rosemary; van Montfort, Rob L. M.; Blagg, Julian; Raynaud, Florence I.; Eccles, Suzanne A.; Hoelder, Swen; Linardopoulos, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1166-1176</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: The main role of the cell cycle is to enable error-free DNA replication, chromosome segregation and cytokinesis.  One of the best characterized checkpoint pathways is the spindle assembly checkpoint, which prevents anaphase onset until the appropriate attachment and tension across kinetochores is achieved.  MPS1 kinase activity is essential for the activation of the spindle assembly checkpoint and has been shown to be deregulated in human tumors with chromosomal instability and aneuploidy.  Therefore, MPS1 inhibition represents an attractive strategy to target cancers.  Methods: To evaluate CCT271850 cellular potency, two specific antibodies that recognize the activation sites of MPS1 were used and its antiproliferative activity was detd. in 91 human cancer cell lines.  DLD1 cells with induced GFP-MPS1 and HCT116 cells were used in in vivo studies to directly measure MPS1 inhibition and efficacy of CCT271850 treatment.  Results: CCT271850 selectively and potently inhibits MPS1 kinase activity in biochem. and cellular assays and in in vivo models.  Mechanistically, tumor cells treated with CCT271850 acquire aberrant nos. of chromosomes and the majority of cells divide their chromosomes without proper alignment because of abrogation of the mitotic checkpoint, leading to cell death.  We demonstrated a moderate level of efficacy of CCT271850 as a single agent in a human colorectal carcinoma xenograft model.  Conclusions: CCT271850 is a potent, selective and orally bioavailable MPS1 kinase inhibitor.  On the basis of in vivo pharmacodynamic vs efficacy relationships, we predict that more than 80% inhibition of MPS1 activity for at least 24 h is required to achieve tumor stasis or regression by CCT271850.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodu8v7zdjvabVg90H21EOLACvtfcHk0ljpFP8ronErzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKht74%253D&md5=656368a488e47677a8cb455de962371e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2017.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2017.75%26sid%3Dliteratum%253Aachs%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.%2BY.%26aulast%3DGurden%26aufirst%3DM.%2BD.%26aulast%3DXavier%26aufirst%3DC.%2BP.%2BR.%26aulast%3DAnderhub%26aufirst%3DS.%2BJ.%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%2BR.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%2BK.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DvanMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DLinardopoulos%26aufirst%3DS.%26atitle%3DCharacterisation%2520of%2520CCT271850%252C%2520a%2520selective%252C%2520oral%2520and%2520potent%2520MPS1%2520inhibitor%252C%2520used%2520to%2520directly%2520measure%2520in%2520vivo%2520MPS1%2520inhibition%2520vs%2520therapeutic%2520efficacy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2017%26volume%3D116%26spage%3D1166%26epage%3D1176%26doi%3D10.1038%2Fbjc.2017.75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solanki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matijssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Rapid discovery of pyrido[3,4-d]pyrimidine inhibitors of monopolar spindle kinase 1 (MPS1) using a structure-based hybridization approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3671</span>– <span class="NLM_lpage">3688</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01811</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01811" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2qsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3671-3688&author=P.+Innocentiauthor=H.+L.+Woodwardauthor=S.+Solankiauthor=S.+Naudauthor=I.+M.+Westwoodauthor=N.+Croninauthor=A.+Hayesauthor=J.+Robertsauthor=A.+T.+Henleyauthor=R.+Bakerauthor=A.+Faisalauthor=G.+W.+Makauthor=G.+Boxauthor=M.+Valentiauthor=A.+De+Haven+Brandonauthor=L.+O%E2%80%99Feeauthor=H.+Savilleauthor=J.+Schmittauthor=B.+Matijssenauthor=R.+Burkeauthor=R.+L.+van+Montfortauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Linardopoulosauthor=J.+Blaggauthor=S.+Hoelder&title=Rapid+discovery+of+pyrido%5B3%2C4-d%5Dpyrimidine+inhibitors+of+monopolar+spindle+kinase+1+%28MPS1%29+using+a+structure-based+hybridization+approach&doi=10.1021%2Facs.jmedchem.5b01811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach</span></div><div class="casAuthors">Innocenti, Paolo; Woodward, Hannah L.; Solanki, Savade; Naud, Sebastien; Westwood, Isaac M.; Cronin, Nora; Hayes, Angela; Roberts, Jennie; Henley, Alan T.; Baker, Ross; Faisal, Amir; Mak, Grace Wing-Yan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; O'Fee, Lisa; Saville, Harry; Schmitt, Jessica; Matijssen, Berry; Burke, Rosemary; van Montfort, Rob L. M.; Raynaud, Florence I.; Eccles, Suzanne A.; Linardopoulos, Spiros; Blagg, Julian; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3671-3688</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (MPS1) plays a central role in the transition of cells from metaphase to anaphase and is one of the main components of the spindle assembly checkpoint.  Chromosomally unstable cancer cells rely heavily on MPS1 to cope with the stress arising from abnormal nos. of chromosomes and centrosomes and are thus more sensitive to MPS1 inhibition than normal cells.  We report the discovery and optimization of a series of new pyrido[3,4-d]pyrimidine based inhibitors via a structure-based hybridization approach from our previously reported inhibitor CCT251455 and a modestly potent screening hit.  Compds. in this novel series display excellent potency and selectivity for MPS1, which translates into biomarker modulation in an in vivo human tumor xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42v6loNvM1bVg90H21EOLACvtfcHk0ljAbhOHtTZe7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2qsro%253D&md5=dd858ed11744e0b036061baf5e2c181a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01811%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DCronin%26aufirst%3DN.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSaville%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DRapid%2520discovery%2520of%2520pyrido%255B3%252C4-d%255Dpyrimidine%2520inhibitors%2520of%2520monopolar%2520spindle%2520kinase%25201%2520%2528MPS1%2529%2520using%2520a%2520structure-based%2520hybridization%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3671%26epage%3D3688%26doi%3D10.1021%2Facs.jmedchem.5b01811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagashira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1760</span>– <span class="NLM_lpage">1775</span>, <span class="refDoi"> DOI: 10.1021/jm501599u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501599u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1760-1775&author=K.-i.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=T.+Yamamotoauthor=H.+Hashizumeauthor=K.+Nozuauthor=H.+Yoshidaauthor=G.+Tadanoauthor=S.+Tagashiraauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=S.+Andoauthor=M.+Maedaauthor=M.+Higakiauthor=Y.+Babaauthor=Y.+Nakamura&title=Discovery+of+imidazo%5B1%2C2-b%5Dpyridazine+derivatives%3A+selective+and+orally+available+Mps1+%28TTK%29+kinase+inhibitors+exhibiting+remarkable+antiproliferative+activity&doi=10.1021%2Fjm501599u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Imidazo[1,2-b]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity</span></div><div class="casAuthors">Kusakabe, Ken-ichi; Ide, Nobuyuki; Daigo, Yataro; Itoh, Takeshi; Yamamoto, Takahiko; Hashizume, Hiroshi; Nozu, Kohei; Yoshida, Hiroshi; Tadano, Genta; Tagashira, Sachie; Higashino, Kenichi; Okano, Yousuke; Sato, Yuji; Inoue, Makiko; Iguchi, Motofumi; Kanazawa, Takayuki; Ishioka, Yukichi; Dohi, Keiji; Kido, Yasuto; Sakamoto, Shingo; Ando, Shigeru; Maeda, Masahiro; Higaki, Masayo; Baba, Yoshiyasu; Nakamura, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1760-1775</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) is an attractive oncol. target due to its high expression level in cancer cells as well as the correlation of its expression levels with histol. grades of cancers.  An imidazo[1,2-a]pyrazine 10a was identified during an HTS campaign.  Although 10a exhibited good biochem. activity, its moderate cellular as well as antiproliferative activities needed to be improved.  The cocrystal structure of an analog of 10a guided our lead optimization to introduce substituents at the 6-position of the scaffold, giving the 6-aryl substituted 21b which had improved cellular activity but no oral bioavailability in rat.  Property-based optimization at the 6-position and a scaffold change led to the discovery of the imidazo[1,2-b]pyridazine-based 27f, an extremely potent (cellular Mps1 IC50 = 0.70 nM, A549 IC50 = 6.0 nM), selective Mps1 inhibitor over 192 kinases, which could be orally administered and was active in vivo.  This 27f demonstrated remarkable antiproliferative activity in the nanomolar range against various tissue cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8D9nRl5vWabVg90H21EOLACvtfcHk0lg8UjMPwp15VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D&md5=bee62a50247a363dc3e35fcdeac6a64f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm501599u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501599u%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DNozu%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C2-b%255Dpyridazine%2520derivatives%253A%2520selective%2520and%2520orally%2520available%2520Mps1%2520%2528TTK%2529%2520kinase%2520inhibitors%2520exhibiting%2520remarkable%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1760%26epage%3D1775%26doi%3D10.1021%2Fjm501599u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uitdehaag, J. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Man, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen-Seegers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinsen, M. B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libouban, M. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterrenburg, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, J. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Vetter, J. R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Roos, J. A. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buijsman, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, G. J. R.</span></span> <span> </span><span class="NLM_article-title">Target residence time-guided optimization on TTK kinase results in inhibitors with potent anti-proliferative activity</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>429</i></span>,  <span class="NLM_fpage">2211</span>– <span class="NLM_lpage">2230</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2017.05.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1016%2Fj.jmb.2017.05.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=28539250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Wiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2017&pages=2211-2230&author=J.+C.+M.+Uitdehaagauthor=J.+de+Manauthor=N.+Willemsen-Seegersauthor=M.+B.+W.+Prinsenauthor=M.+A.+A.+Liboubanauthor=J.+G.+Sterrenburgauthor=J.+J.+P.+de+Witauthor=J.+R.+F.+de%0AVetterauthor=J.+A.+D.+M.+de+Roosauthor=R.+C.+Buijsmanauthor=G.+J.+R.+Zaman&title=Target+residence+time-guided+optimization+on+TTK+kinase+results+in+inhibitors+with+potent+anti-proliferative+activity&doi=10.1016%2Fj.jmb.2017.05.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity</span></div><div class="casAuthors">Uitdehaag, Joost C. M.; de Man, Jos; Willemsen-Seegers, Nicole; Prinsen, Martine B. W.; Libouban, Marion A. A.; Sterrenburg, Jan Gerard; de Wit, Joeri J. P.; de Vetter, Judith R. F.; de Roos, Jeroen A. D. M.; Buijsman, Rogier C.; Zaman, Guido J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">429</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2211-2230</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The protein kinase threonine tyrosine kinase (TTK; also known as Mps1) is a crit. component of the spindle assembly checkpoint and a promising drug target for the treatment of aggressive cancers, such as triple neg. breast cancer.  While the first TTK inhibitors have entered clin. trials, little is known about how the inhibition of TTK with small-mol. compds. affects cellular activity.  The authors studied the selective TTK inhibitor NTRC 0066-0, which was developed in the authors' own lab., together with 11 TTK inhibitors developed by other companies, including Mps-BAY2b, BAY 1161909, BAY 1217389 (Bayer), TC-Mps1-12 (Shionogi), and MPI-0479605 (Myrexis).  Parallel testing shows that the cellular activity of these TTK inhibitors correlates with their binding affinity to TTK and, more strongly, with target residence time.  TTK inhibitors are therefore an example where target residence time dets. activity in in vitro cellular assays.  X-ray structures and thermal stability expts. reveal that the most potent compds. induce a shift of the glycine-rich loop as a result of binding to the catalytic lysine at position 553.  This "lysine trap" disrupts the catalytic machinery.  Based on these insights, the authors developed TTK inhibitors, based on a (5,6-dihydro)pyrimido[4,5-e]indolizine scaffold, with longer target residence times, which further exploit an allosteric pocket surrounding Lys 553.  Their binding mode is new for kinase inhibitors and can be classified as hybrid Type I/Type III.  These inhibitors have very potent anti-proliferative activity that rivals classic cytotoxic therapy.  The authors' findings will open up new avenues for more applications for TTK inhibitors in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT_6mZVMoVTrVg90H21EOLACvtfcHk0lg8UjMPwp15VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Wiuro%253D&md5=c02b149e673dec7b0212b37a4c7b0831</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2017.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2017.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DUitdehaag%26aufirst%3DJ.%2BC.%2BM.%26aulast%3Dde%2BMan%26aufirst%3DJ.%26aulast%3DWillemsen-Seegers%26aufirst%3DN.%26aulast%3DPrinsen%26aufirst%3DM.%2BB.%2BW.%26aulast%3DLibouban%26aufirst%3DM.%2BA.%2BA.%26aulast%3DSterrenburg%26aufirst%3DJ.%2BG.%26aulast%3Dde%2BWit%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3Dde%2BVetter%26aufirst%3DJ.%2BR.%2BF.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%2BA.%2BD.%2BM.%26aulast%3DBuijsman%26aufirst%3DR.%2BC.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%2BR.%26atitle%3DTarget%2520residence%2520time-guided%2520optimization%2520on%2520TTK%2520kinase%2520results%2520in%2520inhibitors%2520with%2520potent%2520anti-proliferative%2520activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2017%26volume%3D429%26spage%3D2211%26epage%3D2230%26doi%3D10.1016%2Fj.jmb.2017.05.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jemaà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senovilla, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brands, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prechtl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegelbauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrieu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castedo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Characterization of novel MPS1 inhibitors with preclinical anticancer activity</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1532</span>– <span class="NLM_lpage">1545</span>, <span class="refDoi"> DOI: 10.1038/cdd.2013.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1038%2Fcdd.2013.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=23933817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2gurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1532-1545&author=M.+Jema%C3%A0author=L.+Galluzziauthor=O.+Keppauthor=L.+Senovillaauthor=M.+Brandsauthor=U.+Boemerauthor=M.+Koppitzauthor=P.+Lienauauthor=S.+Prechtlauthor=V.+Schulzeauthor=G.+Siemeisterauthor=A.+M.+Wengnerauthor=D.+Mumbergauthor=K.+Ziegelbauerauthor=A.+Abrieuauthor=M.+Castedoauthor=I.+Vitaleauthor=G.+Kroemer&title=Characterization+of+novel+MPS1+inhibitors+with+preclinical+anticancer+activity&doi=10.1038%2Fcdd.2013.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of novel MPS1 inhibitors with preclinical anticancer activity</span></div><div class="casAuthors">Jemaa, M.; Galluzzi, L.; Kepp, O.; Senovilla, L.; Brands, M.; Boemer, U.; Koppitz, M.; Lienau, P.; Prechtl, S.; Schulze, V.; Siemeister, G.; Wengner, A. M.; Mumberg, D.; Ziegelbauer, K.; Abrieu, A.; Castedo, M.; Vitale, I.; Kroemer, G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1532-1545</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (MPS1), a mitotic kinase that is overexpressed in several human cancers, contributes to the alignment of chromosomes to the metaphase plate as well as to the execution of the spindle assembly checkpoint (SAC).  Here, we report the identification and functional characterization of three novel inhibitors of MPS1 of two independent structural classes, N-(4-{2-[(2-cyanophenyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}phenyl)-2-phenylacetamide (Mps-BAY1) (a triazolopyridine), N-cyclopropyl-4-{8-[(2-methylpropyl)amino]-6-(quinolin-5-yl)imidazo[1,2-a]pyrazin-3-yl}benzamide (Mps-BAY2a) and N-cyclopropyl-4-{8-(isobutylamino)imidazo[1,2-a]pyrazin-3-yl}benzamide (Mps-BAY2b) (two imidazopyrazines).  By selectively inactivating MPS1, these small inhibitors can arrest the proliferation of cancer cells, causing their polyploidization and/or their demise.  Cancer cells treated with Mps-BAY1 or Mps-BAY2a manifested multiple signs of mitotic perturbation including inefficient chromosomal congression during metaphase, unscheduled SAC inactivation and severe anaphase defects.  Videomicroscopic cell fate profiling of histone 2B-green fluorescent protein-expressing cells revealed the capacity of MPS1 inhibitors to subvert the correct timing of mitosis as they induce a premature anaphase entry in the context of misaligned metaphase plates.  Hence, in the presence of MPS1 inhibitors, cells either divided in a bipolar (but often asym.) manner or entered one or more rounds of abortive mitoses, generating gross aneuploidy and polyploidy, resp.  In both cases, cells ultimately succumbed to the mitotic catastrophe-induced activation of the mitochondrial pathway of apoptosis.  Of note, low doses of MPS1 inhibitors and paclitaxel (a microtubular poison) synergized at increasing the frequency of chromosome misalignments and missegregations in the context of SAC inactivation.  This resulted in massive polyploidization followed by the activation of mitotic catastrophe.  A synergistic interaction between paclitaxel and MPS1 inhibitors could also be demonstrated in vivo, as the combination of these agents efficiently reduced the growth of tumor xenografts and exerted superior antineoplastic effects compared with either compd. employed alone.  Altogether, these results suggest that MPS1 inhibitors may exert robust anticancer activity, either as standalone therapeutic interventions or combined with microtubule-targeting chems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHoriIGxHO_rVg90H21EOLACvtfcHk0li_CAKcK06GfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2gurjI&md5=867fb902b15b6df0f7049b069bd47a4c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2013.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2013.105%26sid%3Dliteratum%253Aachs%26aulast%3DJema%25C3%25A0%26aufirst%3DM.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DSenovilla%26aufirst%3DL.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DKoppitz%26aufirst%3DM.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DSchulze%26aufirst%3DV.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26aulast%3DAbrieu%26aufirst%3DA.%26aulast%3DCastedo%26aufirst%3DM.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DCharacterization%2520of%2520novel%2520MPS1%2520inhibitors%2520with%2520preclinical%2520anticancer%2520activity%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2013%26volume%3D20%26spage%3D1532%26epage%3D1545%26doi%3D10.1038%2Fcdd.2013.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosemund, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prechtl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raschke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisk, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Ahsen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreft, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brands, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegelbauer, K.</span></span> <span> </span><span class="NLM_article-title">Novel MPS1 kinase inhibitors with potent Antitumor Activity</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-15-0500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1158%2F1535-7163.mct-15-0500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=26832791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVSqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=583-592&author=A.+M.+Wengnerauthor=G.+Siemeisterauthor=M.+Koppitzauthor=V.+Schulzeauthor=D.+Kosemundauthor=U.+Klarauthor=D.+Stoeckigtauthor=R.+Neuhausauthor=P.+Lienauauthor=B.+Baderauthor=S.+Prechtlauthor=M.+Raschkeauthor=A.-L.+Friskauthor=O.+von+Ahsenauthor=M.+Michelsauthor=B.+Kreftauthor=F.+von+Nussbaumauthor=M.+Brandsauthor=D.+Mumbergauthor=K.+Ziegelbauer&title=Novel+MPS1+kinase+inhibitors+with+potent+Antitumor+Activity&doi=10.1158%2F1535-7163.mct-15-0500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity</span></div><div class="casAuthors">Wengner, Antje M.; Siemeister, Gerhard; Koppitz, Marcus; Schulze, Volker; Kosemund, Dirk; Klar, Ulrich; Stoeckigt, Detlef; Neuhaus, Roland; Lienau, Philip; Bader, Benjamin; Prechtl, Stefan; Raschke, Marian; Frisk, Anna-Lena; von Ahsen, Oliver; Michels, Martin; Kreft, Bertolt; von Nussbaum, Franz; Brands, Michael; Mumberg, Dominik; Ziegelbauer, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">583-592</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) has been shown to function as the key kinase that activates the spindle assembly checkpoint (SAC) to secure proper distribution of chromosomes to daughter cells.  Here, we report the structure and functional characterization of two novel selective Mps1 inhibitors, BAY 1161909 and BAY 1217389, derived from structurally distinct chem. classes.  BAY 1161909 and BAY 1217389 inhibited Mps1 kinase activity with IC50 values below 10 nmol/L while showing an excellent selectivity profile.  In cellular mechanistic assays, both Mps1 inhibitors abrogated nocodazole-induced SAC activity and induced premature exit from mitosis ("mitotic breakthrough"), resulting in multinuclearity and tumor cell death.  Both compds. efficiently inhibited tumor cell proliferation in vitro (IC50 nmol/L range).  In vivo, BAY 1161909 and BAY 1217389 achieved moderate efficacy in monotherapy in tumor xenograft studies.  However, in line with its unique mode of action, when combined with paclitaxel, low doses of Mps1 inhibitor reduced paclitaxel-induced mitotic arrest by the weakening of SAC activity.  As a result, combination therapy strongly improved efficacy over paclitaxel or Mps1 inhibitor monotreatment at the resp. MTDs in a broad range of xenograft models, including those showing acquired or intrinsic paclitaxel resistance.  Both Mps1 inhibitors showed good tolerability without adding toxicity to paclitaxel monotherapy.  These preclin. findings validate the innovative concept of SAC abrogation for cancer therapy and justify clin. proof-of-concept studies evaluating the Mps1 inhibitors BAY 1161909 and BAY 1217389 in combination with antimitotic cancer drugs to enhance their efficacy and potentially overcome resistance.  Mol Cancer Ther; 15(4); 583-92. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGZQmIvWHFcLVg90H21EOLACvtfcHk0li_CAKcK06GfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVSqt7g%253D&md5=f2b5cf0daf178088479be4be2aefa6b7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-15-0500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-15-0500%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DKoppitz%26aufirst%3DM.%26aulast%3DSchulze%26aufirst%3DV.%26aulast%3DKosemund%26aufirst%3DD.%26aulast%3DKlar%26aufirst%3DU.%26aulast%3DStoeckigt%26aufirst%3DD.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DBader%26aufirst%3DB.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DRaschke%26aufirst%3DM.%26aulast%3DFrisk%26aufirst%3DA.-L.%26aulast%3Dvon%2BAhsen%26aufirst%3DO.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3DKreft%26aufirst%3DB.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26atitle%3DNovel%2520MPS1%2520kinase%2520inhibitors%2520with%2520potent%2520Antitumor%2520Activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D583%26epage%3D592%26doi%3D10.1158%2F1535-7163.mct-15-0500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K.-M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven
Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broccatelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8226</span>– <span class="NLM_lpage">8240</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00690</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8226-8240&author=H.+L.+Woodwardauthor=P.+Innocentiauthor=K.-M.+J.+Cheungauthor=A.+Hayesauthor=J.+Robertsauthor=A.+T.+Henleyauthor=A.+Faisalauthor=G.+W.-Y.+Makauthor=G.+Boxauthor=I.+M.+Westwoodauthor=N.+Croninauthor=M.+Carterauthor=M.+Valentiauthor=A.+De+Haven%0ABrandonauthor=L.+O%E2%80%99Feeauthor=H.+Savilleauthor=J.+Schmittauthor=R.+Burkeauthor=F.+Broccatelliauthor=R.+L.+M.+van+Montfortauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Linardopoulosauthor=J.+Blaggauthor=S.+Hoelder&title=Introduction+of+a+Methyl+Group+Curbs+Metabolism+of+Pyrido%5B3%2C4-d%5Dpyrimidine+Monopolar+Spindle+1+%28MPS1%29+Inhibitors+and+Enables+the+Discovery+of+the+Phase+1+Clinical+Candidate+N2-%282-Ethoxy-4-%284-methyl-4H-1%2C2%2C4-triazol-3-yl%29phenyl%29-6-methyl-N8-neopentylpyrido%5B3%2C4-d%5Dpyrimidine-2%2C8-diamine+%28BOS172722%29&doi=10.1021%2Facs.jmedchem.8b00690"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00690%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.-Y.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DCronin%26aufirst%3DN.%26aulast%3DCarter%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSaville%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DBroccatelli%26aufirst%3DF.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DIntroduction%2520of%2520a%2520Methyl%2520Group%2520Curbs%2520Metabolism%2520of%2520Pyrido%255B3%252C4-d%255Dpyrimidine%2520Monopolar%2520Spindle%25201%2520%2528MPS1%2529%2520Inhibitors%2520and%2520Enables%2520the%2520Discovery%2520of%2520the%2520Phase%25201%2520Clinical%2520Candidate%2520N2-%25282-Ethoxy-4-%25284-methyl-4H-1%252C2%252C4-triazol-3-yl%2529phenyl%2529-6-methyl-N8-neopentylpyrido%255B3%252C4-d%255Dpyrimidine-2%252C8-diamine%2520%2528BOS172722%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8226%26epage%3D8240%26doi%3D10.1021%2Facs.jmedchem.8b00690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">Compound <b>20</b> binds comparably to related 2,5-trisubstituted-7<i>H</i>-pyrrolo-[2,3-<i>d</i>]pyrimidine analogs in the TTK ATP binding pocket (see PDB Code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B4W">6B4W</a>). Similar observed G-loop induced fit and binding site interactions are described in ref <a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">The Schrödinger Small-Molecule Drug Discovery Suite 2017-1, S., LLC, New York, NY, 2017 was used for all crystal structure and small molecule–protein visualization and analysis. Schrödinger Release 2017-1: Maestro, Schrödinger, LLC, New York, NY, 2017. Schrödinger Release 2017-1: Schrödinger Suite 2017-1 Protein Preparation Wizard; Epik, Schrödinger, LLC, New York, NY, 2016; Impact, Schrödinger, LLC, New York, NY, 2016; Prime, Schrödinger, LLC, New York, NY, 2017. Schrödinger Release 2017-1: SiteMap, Schrödinger, LLC, New York, NY, 2017. Halgren, T., “Identifying and characterizing binding sites and assessing druggability,” J. Chem. Inf. Model., 2009, 49, 377–389. Halgren, T., “New method for fast and accurate binding-site identification and analysis,” Chem. Biol. Drug Des., 2007, 69, 146–148.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">In the crystal structure, a molecule of pentaethylene glycol binds adjacent to the ligand and interacts directly with catalytic residue Lys553. The pentaenthylene glycol wraps around residue Lys553 and may influence the conformation of proximal residues. Also, the activation loop is not depicted in the structure, as it was not resolved. The ligand may also form additional interactions with the activation loop residues which are not present in the crystal structure.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">The residue Cys604 is small and fairly unique residue that creates a larger pocket in the hinge region of TTK relative to other kinases. For details refer to <i>J. Med. Chem.</i><b>2017</b>, <i>60</i>, 8989–9002, and references therein.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span> <i>SelectScreen Kinase Profiling Services</i>; <span class="NLM_publisher-name">Thermo Fisher Scientific</span>: <span class="NLM_publisher-loc">WI, USA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+SelectScreen+Kinase+Profiling+Services%3B+Thermo+Fisher+Scientific%3A+WI%2C+USA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSelectScreen%2520Kinase%2520Profiling%2520Services%26pub%3DThermo%2520Fisher%2520Scientific" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flagella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baptista, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodbeck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiske, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honigberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jubb, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katavolos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin-Koh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Mahony, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roose-Girma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urkowitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warming, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaylaoglu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span> <span> </span><span class="NLM_article-title">Effect of selective LRRK2 kinase inhibition on nonhuman primate lung</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">273ra15</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aaa3634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1126%2Fscitranslmed.aaa3634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=25653221" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=273ra15&author=R.+N.+Fujiauthor=M.+Flagellaauthor=M.+Bacaauthor=M.+A.+Baptistaauthor=J.+Brodbeckauthor=B.+K.+Chanauthor=B.+K.+Fiskeauthor=L.+Honigbergauthor=A.+M.+Jubbauthor=P.+Katavolosauthor=D.+W.+Leeauthor=S.+Lewin-Kohauthor=T.+Linauthor=X.+Liuauthor=S.+Liuauthor=J.+P.+Lyssikatosauthor=J.+O%E2%80%99Mahonyauthor=M.+Reicheltauthor=M.+Roose-Girmaauthor=Z.+Shengauthor=T.+Shererauthor=A.+Smithauthor=M.+Solonauthor=Z.+K.+Sweeneyauthor=J.+Tarrantauthor=A.+Urkowitzauthor=S.+Warmingauthor=M.+Yaylaogluauthor=S.+Zhangauthor=H.+Zhuauthor=A.+A.+Estradaauthor=R.+J.+Watts&title=Effect+of+selective+LRRK2+kinase+inhibition+on+nonhuman+primate+lung&doi=10.1126%2Fscitranslmed.aaa3634"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa3634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa3634%26sid%3Dliteratum%253Aachs%26aulast%3DFuji%26aufirst%3DR.%2BN.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DBaca%26aufirst%3DM.%26aulast%3DBaptista%26aufirst%3DM.%2BA.%26aulast%3DBrodbeck%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26aulast%3DHonigberg%26aufirst%3DL.%26aulast%3DJubb%26aufirst%3DA.%2BM.%26aulast%3DKatavolos%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLewin-Koh%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DJ.%26aulast%3DReichelt%26aufirst%3DM.%26aulast%3DRoose-Girma%26aufirst%3DM.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DSherer%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DSolon%26aufirst%3DM.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DUrkowitz%26aufirst%3DA.%26aulast%3DWarming%26aufirst%3DS.%26aulast%3DYaylaoglu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DEffect%2520of%2520selective%2520LRRK2%2520kinase%2520inhibition%2520on%2520nonhuman%2520primate%2520lung%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D273ra15%26doi%3D10.1126%2Fscitranslmed.aaa3634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Two decades under the influence of the rule of five and the changing properties of approved oral drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1701</span>– <span class="NLM_lpage">1704</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00686</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00686" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=1701-1704&author=M.+D.+Shultz&title=Two+decades+under+the+influence+of+the+rule+of+five+and+the+changing+properties+of+approved+oral+drugs&doi=10.1021%2Facs.jmedchem.8b00686"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00686%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DTwo%2520decades%2520under%2520the%2520influence%2520of%2520the%2520rule%2520of%2520five%2520and%2520the%2520changing%2520properties%2520of%2520approved%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D62%26spage%3D1701%26epage%3D1704%26doi%3D10.1021%2Facs.jmedchem.8b00686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minor, W.</span></span> <span> </span><span class="NLM_article-title">[20] Processing of X-ray diffraction data collected in oscillation mode</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1016/s0076-6879(97)76066-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=%5B20%5D+Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode&doi=10.1016%2Fs0076-6879%2897%2976066-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0lgBGIcJbsYN6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3D%255B20%255D%2520Processing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326%26doi%3D10.1016%2Fs0076-6879%2897%2976066-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/s0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2Fs0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lgWh-ahYh8OfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2Fs0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/s0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2Fs0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lgWh-ahYh8OfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2Fs0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/s0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2Fs0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lgWh-ahYh8OfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2Fs0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N6O" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N6O','PDB','6N6O'); return false;">PDB: 6N6O</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B4W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B4W','PDB','6B4W'); return false;">PDB: 6B4W</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i39"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01869">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_42366"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01869">10.1021/acs.jmedchem.8b01869</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Rat PO PK for compound <b>1</b>, averages and SEM values for potency and PK data, in vitro kinase selectivity data for compound <b>20</b>, additional TTK crystal structure views, BWL graph for xenograft study, and experimental procedures for intermediates (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_001.pdf">jm8b01869_si_001.pdf (411.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01869/suppl_file/jm8b01869_si_002.csv">jm8b01869_si_002.csv (1.74 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01869%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-9" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01869" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a48605f013db8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
